home.social

Search

1000 results for “BethC”

  1. BetaCodex Network | since 2008 @BetaCodex ·

    A news blog post by
    redforty2.com/post/5-years-of-

    #red42 #betacodex #5yearsofopenspacebeta #agile #lean #openspacebeta
  2. 66gardeners @[email protected] ·

    @krajamine

    These are the terpenes found in cherries.

    The general population, at large, has never heard of terpenoids. Two physicians I've seen in the last six months had no idea what terpenes are.

    If you care about healing and feeling better, you need to educate yourself about terpenes.

    #linalool
    #Betacarophyllin
    #limonene
    #Alphapinene. #Betapinene
    #Myrcene
    #terpenes

    #betacarophyllin #alphapinene #betapinene #linalool #limonene #myrcene
  3. Niels Pflaeging @[email protected] ·

    You cannot motivate other people.
    You cannot develop other people.
    You cannot convince other people.
    You cannot lead other people.
    You cannot steer or control other people.
    You cannot align other people.

    And you don't have to.

    #betacodex #leadership #love #democracy #communication #newwork #futureofleadership #theoryY #motivation #orgdev #agile #agility #lean #selforganization #selforganized

    #betacodex #leadership #love #democracy #communication #newwork
  4. BetaCodex Network | since 2008 @[email protected] ·

    In this video, #BetaCodex Network co-founder @nielspflaeging neatly explains how our community has progressed since 2008, and how we have come much closer to help organizations in the world adopt consistently #selforganized, #decentralized and #democratic organizational models!
    youtube.com/watch?v=958fRoDNOb

    #leadership #transformation #openspacebeta #cellstructuredesign #newwork #futureofleadership #orgesign #orgdev #organizationaldevelopment #newleadership

    #betacodex #selforganized #decentralized #democratic #leadership #transformation
  5. Niels Pflaeging @[email protected] ·

    The #BetaCodex Meetup is open to anyone, internationally. Sign up if you want to be part of the Beta movement. If you are interested into consistently #selforganized & #decentralized organization. If you want to have serious conversation with peers about BetaCodex, and stuff like #RelativeTargets, #CellStructureDesign and #OpenSpaceBeta!
    meetup.com/meetup-group-betaco

    @rijon @peterproell @silkehermann Hermann #agiletransformation #leadership #orgdev #organizationaldevelopment #agile #agility #teal

    #betacodex #selforganized #decentralized #relativetargets #cellstructuredesign #openspacebeta
  6. BetaCodex Network | since 2008 @[email protected] ·

    We just gave the #BetaCodex YouTube channel a GOOD overhaul! Check it out:
    youtube.com/channel/UCV-MhTbWd

    #leadership #change #transformaiton #orgdev #orgdesign #agile #lean #beyondbudgeting #orgphysics #openspacebeta #cellstructuredesign #relativetargets #organizationaldevelopment

    #betacodex #leadership #change #transformaiton #orgdev #orgdesign
  7. Niels Pflaeging @[email protected] ·

    Watch the recording from today's #BetaCodexLIVE conversation between @rijon and myself on "Improving Social Systems":

    youtube.com/watch?v=zn8cNtHDx9

    #kilmann #tki #betacodex #transformation #sociology #research #changeasflipping #openspacebeta #orgdesign #orgdev

    #betacodexlive #kilmann #tki #betacodex #transformation #sociology
  8. BetaCodex Network | since 2008 @[email protected] ·

    For the #BetaCodexLIVE event this Friday, @rijon and @nielspflaeging recorded a little teaser trailer: linkedin.com/posts/betacodex-n

    #orgdev #orgdesign #systemsthinking #sociology #kilmann #orgphysics #science #businessbooks #leadership #newwork

    #betacodexlive #orgdev #orgdesign #systemsthinking #sociology #kilmann
  9. Moshville Times @[email protected] ·

    Beth Hart announces new album “You Still Got Me”

    Grammy-nominated powerhouse singer-songwriter Beth Hart has announced her new studio album, You Still Got Me, which will be released on 25 October via Provogue / Mascot Label Group. The album features appearances by Eric Gales and Slash. She has also revealed her new song, "Wonderful World" - watch the lyric video below.

    Be

    moshville.co.uk/news/2024/08/b

    #News #BethHart

    #bethhart #news
  10. Moshville Times @[email protected] ·

    Beth Hart reveals “You Still Got Me”

    Beth Hart has released her beautiful new single, "You Still Got Me." The song is released on Provogue / Mascot Label Group and is available on all streaming platforms. You can watch the heartfelt video below.

    The video features footage of Hart interacting with her fans, a connection that is felt deeply in both directions, along with personal fo

    moshville.co.uk/video/2024/06/

    #Videos #BethHart

    #bethhart #videos
  11. BetaCodex Network | since 2008 @[email protected] ·

    We gave this page on the #BetaCodexNetwork website a thorough update.
    It needed one!
    betacodex.org/learningbeta/

    Please let us know in case we missed something.
    #betacodex #learningbeta #betalearning #corporatelearning #qomenius #agile #transformation #newwork

    #betacodexnetwork #betacodex #learningbeta #betalearning #corporatelearning #qomenius
  12. Jason Kautz :warriors: @[email protected] ·

    @BetaCuck4Lyfe @seachanger so far, I've yet to witness any country, Western or otherwise, properly orchestrate "equality" so instead there's caste, unfortunately .... even if Abrahamic existential narratives fail to absorb such a concept vis a vis Gaza, etc ... #meritocracy is something we'll sometimes call it;maybe that's more "progressive" or something. ultimately, at scale, we have to learn non-violence despite our existential fears but i'm crazy 🫠️ #convoluted

    #meritocracy #convoluted
  13. BetaCodex Network | since 2008 @[email protected] ·

    Also brand new from #BetaCodexPress:
    What would Drucker do? - with more than 160 quotes by the greatest management thinker of all times. Now available everywhere!
    Take a look inside the book: redforty2.com/product-page/wha #drucker #peterdrucker #management #leadership

    #betacodexpress #drucker #peterdrucker #management #leadership
  14. Niels Pflaeging @[email protected] ·

    Today our new online event format #BetaCodex Live premiered! @rijon and I
    talked about my new book #WhatWouldDemingDo and Peter Drucker's legacy for OUR times. Watch the recording now: youtube.com/watch?v=KxAF5P8v2-

    #drucker #peterdrucker #agile #leadership #newwork #agile #lean

    #betacodex #whatwoulddemingdo #drucker #peterdrucker #agile #leadership
  15. Niels Pflaeging @[email protected] ·

    News from #BetaCodexPress and the #BetaCodex Network!

    redforty2.com/post/today-what-

    Join today's live event. Free of charge.

    #betacodex #drucker #whatwoulddruckerdo #peterdrucker #leadership #management #organizationaldevelopment #orgdev #newleadership #newwork #hr #agile #lean #agiletransformation #agility #selforganization #systemsthinking #culturechange #changemanagement

    #betacodexpress #betacodex #drucker #whatwoulddruckerdo #peterdrucker #leadership
  16. Niels Pflaeging @[email protected] ·

    Here I talk about what Isaac Newton and Peter Drucker have in common.
    youtube.com/watch?v=zAXLPBb5nF
    #betacodexpress #whatwoulddruckerdo #drucker #leadership #futureofleadeership #newleadership #management #peterdrucker #betacodex

    #betacodex #betacodexpress #whatwoulddruckerdo #drucker #leadership #futureofleadeership
  17. Niels Pflaeging @[email protected] ·

    My new book "What would Drucker do?" has been released today!
    youtube.com/watch?v=-2Q3Jan3Cw
    #betacodexpress #whatwoulddruckerdo #drucker #leadership #futureofleadership #newleadership #management #peterdrucker #betacodex

    #betacodexpress #whatwoulddruckerdo #drucker #leadership #newleadership #management
  18. Giuseppe Michieli @[email protected] ·

    Murine #betacoronavirus #spike protein: A major #determinant of #neuropathogenic properties, etidiohnew.blogspot.com/2025/0

    #betacoronavirus #spike #determinant #neuropathogenic
  19. ETIDIoH @[email protected] ·

    #Coronavirus Disease Research #References (by AMEDEO, December 7 ’24)

    1. VASSILOPOULOS S, Mylonakis E
      After COVID-19 diagnosis, risk for incident type 2 diabetes was elevated for up to 2 y.
      Ann Intern Med. 2024 Dec 3. doi: 10.7326/ANNALS-24-02887.
      PubMed         Abstract available

      Antiviral Res

    2. SCHRELL L, Fuchs HL, Dickmanns A, Scheibner D, et al
      Inhibitors of dihydroorotate dehydrogenase synergize with the broad antiviral activity of 4′-fluorouridine.
      Antiviral Res. 2024 Dec 3:106046. doi: 10.1016/j.antiviral.2024.106046.
      PubMed         Abstract available

      Br J Anaesth

    3. SPARLING JL, Chitilian HV, Korn E, Alfille PH, et al
      Induction of anaesthesia and airway management in patients with severe tracheal stenosis: a single-centre retrospective study.
      Br J Anaesth. 2024 Dec 4:S0007-0912(24)00667-6. doi: 10.1016/j.bja.2024.
      PubMed        

      Emerg Infect Dis

    4. HASSAN AM, Muhlemann B, Al-Subhi TL, Rodon J, et al
      Ongoing Evolution of Middle East Respiratory Syndrome Coronavirus, Saudi Arabia, 2023-2024.
      Emerg Infect Dis. 2024;31.
      PubMed         Abstract available

      Infect Control Hosp Epidemiol

    5. KIM T, Moehring RW, Turner NA, Ashley ED, et al
      Long-term trends in the incidence of hospital-acquired carbapenem-resistant Enterobacterales and antimicrobial utilization in a network of community hospitals in the Southeastern United States from 2013 to 2023.
      Infect Control Hosp Epidemiol. 2024 Dec 3:1-7. doi: 10.1017/ice.2024.
      PubMed         Abstract available
    6. USIAK S, Aslam A, Yan J, Madhavappallil J, et al
      Utility of post-admission SARS-CoV-2 serial testing in hospitalized patients with cancer.
      Infect Control Hosp Epidemiol. 2024 Dec 3:1-3. doi: 10.1017/ice.2024.
      PubMed         Abstract available
    7. PASSARETTI CL, Bischoff W, Chan J, Diekema DJ, et al
      Respiratory equality: let’s stop playing favorites with COVID-19 in the healthcare setting.
      Infect Control Hosp Epidemiol. 2024 Dec 4:1-2. doi: 10.1017/ice.2024.
      PubMed        

      Int J Infect Dis

    8. IP B, Pan S, Yao A, Lau L, et al
      COVID-19 vaccination and cerebral small vessel disease progression – A prospective cohort study.
      Int J Infect Dis. 2024 Dec 3:107324. doi: 10.1016/j.ijid.2024.107324.
      PubMed         Abstract available

      J Infect

    9. PENG Y, Shen H, Zhang Y, Zeng S, et al
      A comprehensive pan-cancer analysis of SARS-CoV-2-related cancer malignancy: COVID-19 infection shapes a dynamic immune microenvironment and affects the prognosis.
      J Infect. 2024 Nov 30:106364. doi: 10.1016/j.jinf.2024.106364.
      PubMed        

      J Med Virol

    10. ZWYGART AC, Medaglia C, Zhu Y, Bart Tarbet E, et al
      Development of Broad-Spectrum beta-Cyclodextrins-Based Nanomaterials Against Influenza Viruses.
      J Med Virol. 2024;96:e70101.
      PubMed         Abstract available
    11. STICH M, Magalhaes VG, Burger F, Garbade SF, et al
      Elevated Soluble ACE2 Activity in Children and Adults After SARS-CoV-2 Exposure Irrespective of Laboratory-Confirmed Infection.
      J Med Virol. 2024;96:e70098.
      PubMed         Abstract available
    12. MAIMAITI M, Kong L, Yu Q, Wang Z, et al
      Analytical Performance of a Novel Nanopore Sequencing for SARS-CoV-2 Genomic Surveillance.
      J Med Virol. 2024;96:e70108.
      PubMed         Abstract available

      J Virol

    13. ZUO F, Cao Y, Sun R, Wang Q, et al
      Ultrapotent IgA dimeric antibodies neutralize emerging Omicron variants.
      J Virol. 2024 Dec 4:e0174024. doi: 10.1128/jvi.01740.
      PubMed        
    14. ZHANG Y, Zhang N, Zhang Y, Li Y, et al
      Potassium molybdate blocks APN-dependent coronavirus entry by degrading receptor via PIK3C3-mediated autophagy.
      J Virol. 2024 Dec 6:e0144924. doi: 10.1128/jvi.01449.
      PubMed         Abstract available

      JAMA

    15. ANDERER S
      CDC Recommends Second COVID-19 Vaccine Dose for Older Adults.
      JAMA. 2024 Dec 6. doi: 10.1001/jama.2024.24258.
      PubMed        

      Nature

    16. KUDIABOR H
      Virtual lab powered by ‘AI scientists’ super-charges biomedical research.
      Nature. 2024 Dec 4. doi: 10.1038/d41586-024-01684.
      PubMed        

      Science

    17. KAISER J
      Trump picks an ‘outsider’ and NIH critic to lead agency.
      Science. 2024;386:1080-1081.
      PubMed         Abstract available

    #betacoronavirus #covid #COVID19 #health #mentalHealth #research #sarbecovirus #sarsCov2 #science

    #betacoronavirus #covid #covid19 #health #mentalhealth #research
  20. ETIDIoH @[email protected] ·
    1. SELINGER S
      Patients surviving COVID-19 had lower risk for long COVID in the Omicron vs. earlier eras.
      Ann Intern Med. 2024 Nov 5. doi: 10.7326/ANNALS-24-02441.
      PubMed         Abstract available

      BMJ

    2. BARRETT A
      Covid-19: Australian inquiry calls for establishment of a national centre for disease control and action to tackle inequities.
      BMJ. 2024;387:q2420.
      PubMed        

      Clin Infect Dis

    3. MORTEZAVI M, Sloan A, Singh RSP, Chen LF, et al
      Virologic Response and Safety of Ibuzatrelvir, a Novel SARS-CoV-2 Antiviral, in Adults With COVID-19.
      Clin Infect Dis. 2024 Nov 2:ciae529. doi: 10.1093.
      PubMed         Abstract available

      Int J Infect Dis

    4. NAVEED Z, Li J, Wilton J, Naus M, et al
      Healthcare utilization among COVID-19 mRNA vaccine-associated myocarditis cases: a matched retrospective cohort study.
      Int J Infect Dis. 2024 Nov 1:107287. doi: 10.1016/j.ijid.2024.107287.
      PubMed         Abstract available
    5. EPSTEIN-SHUMAN A, Hunt JH, Caturegli P, Winguth P, et al
      Autoantibodies Directed Against Interferon Alpha, Nuclear Antigens, Cardiolipin, and Beta 2 Glycoprotein 1 Are Not Induced By SARS-CoV-2 or Associated with Long COVID.
      Int J Infect Dis. 2024 Nov 1:107289. doi: 10.1016/j.ijid.2024.107289.
      PubMed         Abstract available

      Intensive Care Med

    6. WANG Y, Hao S, Song J, Zhong M, et al
      Reflections on awake prone positioning in COVID-19: considerations on body inclination, respiratory support, and patient variability.
      Intensive Care Med. 2024 Nov 4. doi: 10.1007/s00134-024-07710.
      PubMed        

      J Infect

    7. WANG H, Zhou Y, Chu L, Chen K, et al
      Guardian-driven influenza vaccination intentions for children post-COVID-19 in the 2024-2025 season: The positive spillover effects.
      J Infect. 2024;89:106333.
      PubMed        
    8. HO A, McInnes N, Blunsum A, Quinn J, et al
      Near real-time severe acute respiratory illness surveillance characterising influenza and COVID-19 epidemiology in hospitalised adults, 2021-22.
      J Infect. 2024;89:106338.
      PubMed         Abstract available

      J Virol

    9. CHEN D, Zhang W, Xiao B, Xu B, et al
      Effect of wild-type vaccine doses on BA.5 hybrid immunity, disease severity, and XBB reinfection risk.
      J Virol. 2024 Nov 5:e0128524. doi: 10.1128/jvi.01285.
      PubMed         Abstract available
    10. STEIN SC, Hansen G, Ssebyatika G, Stroh LJ, et al
      A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing the L452R mutation.
      J Virol. 2024 Nov 4:e0122324. doi: 10.1128/jvi.01223.
      PubMed         Abstract available
    11. PARRY RH, Lytras S, Petrone ME, Wille M, et al
      No evidence that mutations in SARS-CoV-2 variants of concern derive from homologous fragments in gut microbiota.
      J Virol. 2024 Nov 4:e0146824. doi: 10.1128/jvi.01468.
      PubMed         Abstract available

      Life Sci

    12. MARANGI M, Boughattas S, Benslimane F
      Gut microbiome profile to the level species in diarrheic protozoan-carrier patients in Italy.
      Life Sci. 2024 Oct 25:123182. doi: 10.1016/j.lfs.2024.123182.
      PubMed         Abstract available
    13. ASHRAF MS, Tuli K, Moiz S, Sharma SK, et al
      AMP kinase: A promising therapeutic drug target for post-COVID-19 complications.
      Life Sci. 2024;359:123202.
      PubMed         Abstract available

      Zhonghua Jie He He Hu Xi Za Zhi

    14. LIANG SF, Li WM, Liu D
      [Progress and challenges in clinical diagnosis and treatment of co-existent lung cancer and pulmonary tuberculosis].
      Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:1035-1041.
      PubMed         Abstract available

    https://etidioh.wordpress.com/2024/11/10/coronavirus-disease-research-references-by-amedeo-nov-10-24/

    #betacoronavirus #cancer #coronavirus #covid #COVID19 #health #mentalHealth #research #sarbecovirus #sarsCov2

    #betacoronavirus #cancer #coronavirus #covid #covid19 #health
  21. ETIDIoH @[email protected] ·

    Source: New Microbes New Infections, https://www.sciencedirect.com/science/article/pii/S2052297524003007?via%3Dihub

    {Excerpt}

    Dear Editor:
    On 5 September 2024, the Ministry of Health of Saudi Arabia confirmed the first human case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Pakistan [1]. This phenomene highlights an urgent epidemiological concern regarding the surveillance and response mechanisms in public health. Notably, since 2019, there have been no MERS-CoV cases reported outside the Middle East. The patient, a male aged between 50 and 55 years from Saudi Arabia’s Eastern Region, presented with symptoms of fever, cough, shortness of breath, and palpitations on 28 August. He was admitted as a cardiac patient to a local hospital on 31 August and transferred to a medical complex on 1 September, where he was discharged against medical advice on the same day. A nasopharyngeal swab taken on 1 September returned a positive MERS-CoV result on 4 September through real-time polymerase chain reaction. The patient traveled to Pakistan on 2 September, prior to receiving his results. The patient, who was not a healthcare worker, had several comorbidities. Field investigations did not reveal any camel exposure. Monitoring of one household member, 23 healthcare workers, and two patients with contact in Saudi Arabia revealed no secondary cases. One individual traveled to South Asia on 4 September, but no further cases were identified through contact tracing. Following notification from Saudi Arabia’s International Health Regulations National Focal Point on 5 September, Pakistani health authorities located the patient and placed him in isolation. Forty-one nasopharyngeal samples, including repeated samples from the patient and close contacts, were tested at Pakistan’s National Institute of Health. The patient tested positive, although with a low viral load, while all close contacts tested negative. No secondary cases were identified after 14 days of observation. This case underscores the growing threat posed by zoonotic diseases, particularly in regions where human-animal interactions are frequent. It also emphasizes the risk of MERS-CoV outbreaks in South Asia, extending beyond the traditional Middle East region.

    (…)

    ____

    https://etidioh.wordpress.com/2024/11/05/pakistans-first-mers-cov-case-a-wake-up-call-for-global-health-authorities/

    #betacoronavirus #coronavirus #health #merbecovirus #mersCov #pakistan #research #saudiArabia #SAUDIARABIA

    #betacoronavirus #coronavirus #health #merbecovirus #merscov #pakistan
  22. ETIDIoH @[email protected] ·
    1. NAKASHIMA M, Nobori H, Kuroda T, Shimba A, et al
      Oral 3CL protease inhibitor ensitrelvir suppressed SARS-CoV-2 shedding and infection in a hamster aerosol transmission model.
      Antiviral Res. 2024 Oct 28:106026. doi: 10.1016/j.antiviral.2024.106026.
      PubMed         Abstract available

      BMJ

    2. DOWNAR J, Close E, Young JE, White BP, et al
      Assisted dying: balancing safety with access.
      BMJ. 2024;387:q2382.
      PubMed        

      Clin Infect Dis

    3. BHIMRAJ A, Falck-Ytter Y, Kim AY, Li JZ, et al
      2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis.
      Clin Infect Dis. 2024 Oct 29:ciae435. doi: 10.1093.
      PubMed         Abstract available

      Infect Control Hosp Epidemiol

    4. QADDOURA A, McQuiston M, Tyrrell G, Croxen M, et al
      Analysis of invasive group A streptococcal puerperal sepsis in Calgary, Alberta: clinical consequences and policy implications.
      Infect Control Hosp Epidemiol. 2024;45:1-4.
      PubMed         Abstract available

      J Med Virol

    5. SONG K, Hasan A, Hao W, Wu Y, et al
      Stimulator of interferon genes (STING) inhibits coronavirus infection by disrupting viral replication organelles.
      J Med Virol. 2024;96:e70020.
      PubMed         Abstract available
    6. YILDIZ Y, Yasar E, Ozturk E, Karakan MS, et al
      Heterologous Versus Homologous COVID-19 Boosters: Immune Response Outcomes in Renal Transplant Recipients.
      J Med Virol. 2024;96:e70030.
      PubMed         Abstract available

      J Virol

    7. LIU X, Zhang M, Yin L, Kang L, et al
      PEDV evades MHC-I-related immunity through nsp1-mediated NLRC5 translation inhibition.
      J Virol. 2024 Oct 31:e0142124. doi: 10.1128/jvi.01421.
      PubMed         Abstract available
    8. SHI L, Duan Y, Cao L, Zhang Y, et al
      PF-00835231 broadly inhibits swine Alpha-coronavirus, including emerging SADS-CoV.
      J Virol. 2024 Oct 31:e0130324. doi: 10.1128/jvi.01303.
      PubMed         Abstract available
    9. HOFFMANN M, Kleine-Weber H, Graichen L, Nehlmeier I, et al
      Acquisition of a multibasic cleavage site does not increase MERS-CoV entry into Calu-3 human lung cells.
      J Virol. 2024 Oct 29:e0130524. doi: 10.1128/jvi.01305.
      PubMed         Abstract available

      JAMA

    10. TADROUS M, Callaway Kim K, Hernandez I, Rothenberger SD, et al
      Differences in Drug Shortages in the US and Canada.
      JAMA. 2024 Oct 31. doi: 10.1001/jama.2024.17688.
      PubMed         Abstract available

      Lancet Infect Dis

    11. PASCAL G
      COVID-19 in South Asia.
      Lancet Infect Dis. 2024 Oct 22:S1473-3099(24)00723.
      PubMed        
    12. OKADA Y, Kumagai Y, Okura I, Otsuki M, et al
      Immunogenicity of a booster dose of a bivalent (Asp614Gly and omicron BA.4/5 variant) self-amplifying mRNA SARS-CoV-2 booster vaccine versus the BNT162b2 omicron BA.4/5 mRNA vaccine: a randomised phase 3 trial.
      Lancet Infect Dis. 2024 Oct 23:S1473-3099(24)00565.
      PubMed         Abstract available

      Life Sci

    13. YU LC
      Gastrointestinal pathophysiology in long COVID: Exploring roles of microbiota dysbiosis and serotonin dysregulation in post-infectious bowel symptoms.
      Life Sci. 2024;358:123153.
      PubMed         Abstract available
    14. WANG N, Fan H, Wang Y, Shu C, et al
      The hybrid immunity defined by weaker immune imprinting of people living with HIV has a stronger neutralizing response against Omicron variants. A suggested explanation for fewer symptoms in people living with HIV after SARS-CoV-2 variants breakthroug
      Life Sci. 2024 Oct 29:123197. doi: 10.1016/j.lfs.2024.123197.
      PubMed         Abstract available

      MMWR Morb Mortal Wkly Rep

    15. BELL J, Meng L, Barbre K, Wong E, et al
      Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel – National Healthcare Safety Network, United States, 2023-24 Respiratory Virus Season.
      MMWR Morb Mortal Wkly Rep. 2024;73:966-972.
      PubMed         Abstract available
    16. JONES CE, Danovaro-Holliday MC, Mwinnyaa G, Gacic-Dobo M, et al
      Routine Vaccination Coverage – Worldwide, 2023.
      MMWR Morb Mortal Wkly Rep. 2024;73:978-984.
      PubMed         Abstract available

      N Engl J Med

    17. LITWINSKA-KMIECIK A, Mrowczynski K
      Postacute Sequelae of SARS-CoV-2 Infection in Several Eras.
      N Engl J Med. 2024;391:1658-1659.
      PubMed        
    18. YANG C, Tebbutt SJ
      Postacute Sequelae of SARS-CoV-2 Infection in Several Eras.
      N Engl J Med. 2024;391:1659.
      PubMed        
    19. XIE Y, Al-Aly Z
      Postacute Sequelae of SARS-CoV-2 Infection in Several Eras. Reply.
      N Engl J Med. 2024;391:1659-1660.
      PubMed        

      Nature

    20. LIU P, Huang ML, Guo H, McCallum M, et al
      Design of customized coronavirus receptors.
      Nature. 2024 Oct 30. doi: 10.1038/s41586-024-08121.
      PubMed         Abstract available

      Science

    21. LONG K
      Keeping outbreaks at bayCrisis Averted: The Hidden Science of Fighting Outbreaks Caitlin Rivers Viking, 2024. 320 pp.
      Science. 2024;386:499.
      PubMed         Abstract available
    22. KUPFERSCHMIDT K
      You won’t believe this.
      Science. 2024;386:483-485.
      PubMed         Abstract available

    https://etidioh.wordpress.com/2024/11/03/coronavirus-disease-research-references-by-amedeo-nov-3-24/

    #betacoronavirus #coronavirus #covid #COVID19 #health #research #sarbecovirus #sarsCov2 #science

    #betacoronavirus #coronavirus #covid #covid19 #health #research
  23. ETIDIoH @[email protected] ·
    1. VAN DER HORST D, Carter-Timofte ME, Danneels A, Silva da Costa L, et al
      Large-scale deep learning identifies the antiviral potential of PKI-179 and MTI-31 against coronaviruses.
      Antiviral Res. 2024;231:106012.
      PubMed         Abstract available

      BMJ

    2. IACOBUCCI G
      Covid inquiry hears harrowing evidence of effects on ICU staff.
      BMJ. 2024;386:q2125.
      PubMed        
    3. NABAVI N
      Mix of relief and disappointment-striking a balance in the pay deal for resident doctors in England.
      BMJ. 2024;386:q2116.
      PubMed        
    4. BOUM Y 2ND, Ndembi N
      Mpox needs a locally tailored global response.
      BMJ. 2024;386:q2094.
      PubMed        
    5. DARLOW J
      Is the NHS “broken”? Staff haven’t given up, neither should our politicians.
      BMJ. 2024;386:q2130.
      PubMed        
    6. DEMASI M
      Journal retracts Covaxin study after manufacturer sues for defamation.
      BMJ. 2024;386:q2119.
      PubMed        
    7. Seven days in medicine: 18-24 September 2024.
      BMJ. 2024;386:q2087.
      PubMed        
    8. TANNE JH
      Whooping cough: Fivefold rise in US cases spells return to pre-pandemic levels.
      BMJ. 2024;386:q2114.
      PubMed        
    9. MAHASE E
      Politicians are failing to prepare for next pandemic, warns head of European health agency.
      BMJ. 2024;386:q2115.
      PubMed        
    10. MAHASE E
      Covid inquiry: UKHSA chief is challenged on view that evidence for FFP3 masks is “weak”.
      BMJ. 2024;386:q2075.
      PubMed        

      Clin Infect Dis

    11. TRAN KC, Asfar P, Cheng M, Demiselle J, et al
      Effects of Losartan on Patients Hospitalized for Acute COVID-19: A Randomized Controlled Trial.
      Clin Infect Dis. 2024;79:615-625.
      PubMed         Abstract available
    12. FONG Y, Dang L, Zhang B, Fintzi J, et al
      Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.
      Clin Infect Dis. 2024 Sep 26:ciae465. doi: 10.1093.
      PubMed         Abstract available
    13. Correction to: Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the COVID-19 Outbreak: An Interrupted Time series Analysis of 2017-2021 Data.
      Clin Infect Dis. 2024 Sep 25:ciae455. doi: 10.1093.
      PubMed        

      Emerg Infect Dis

    14. CHARLES H, Thorley K, Turner C, Bennet KF, et al
      Mpox Epidemiology and Vaccine Effectiveness, England, 2023.
      Emerg Infect Dis. 2024;30:2145-2148.
      PubMed         Abstract available
    15. WERNIKE K, Mehl C, Aebischer A, Ulrich L, et al
      SARS-CoV-2 and Other Coronaviruses in Rats, Berlin, Germany, 2023.
      Emerg Infect Dis. 2024;30:2205-2208.
      PubMed         Abstract available
    16. LININGER N, Falender R, Cieslak P, Novak A, et al
      Correlation between Viral Wastewater Concentration and Respiratory Tests, Oregon, USA.
      Emerg Infect Dis. 2024;30:2194-2196.
      PubMed         Abstract available

      Infect Control Hosp Epidemiol

    17. BRANCH-ELLIMAN W, Banach DB, Batshon LJ, Dumyati G, et al
      SHEA position statement on pandemic preparedness for policymakers: pandemic data collection, maintenance, and release.
      Infect Control Hosp Epidemiol. 2024;45:821-825.
      PubMed         Abstract available
    18. HSU VP, Pergam SA, Shenoy ES, Banach DB, et al
      SHEA position statement on pandemic preparedness for policymakers: emerging infectious threats.
      Infect Control Hosp Epidemiol. 2024;45:818-820.
      PubMed        
    19. DEWITT ME, Sampson MM, Kester S, MacNeill E, et al
      Racial disparities in central line-associated bloodstream infections: the impact of the COVID-19 pandemic.
      Infect Control Hosp Epidemiol. 2024 Sep 26:1-5. doi: 10.1017/ice.2024.
      PubMed         Abstract available

      Int J Infect Dis

    20. LEE JA, Jang H, Ahn SM, Seong JE, et al
      Estimates of Vaccine Effectiveness of the Updated Monovalent XBB.1.5 COVID-19 Vaccine Against Symptomatic SARS-CoV-2 Infection, Hospitalization, and Receipt of Oxygen Therapy in South Korea – October 26 to December 31, 2023.
      Int J Infect Dis. 2024 Sep 20:107249. doi: 10.1016/j.ijid.2024.107249.
      PubMed         Abstract available
    21. TAKAHASHI H, Morikawa M, Satake Y, Nagamatsu H, et al
      Diagnostic Utility of Pharyngeal Follicular Structures in COVID-19: A Large-scale Cross-Sectional Study.
      Int J Infect Dis. 2024 Sep 21:107244. doi: 10.1016/j.ijid.2024.107244.
      PubMed         Abstract available

      J Infect

    22. MCLEOD C, Dymock, Flanagan KL, Plebanski M, et al
      The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): the immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old.
      J Infect. 2024 Sep 26:106286. doi: 10.1016/j.jinf.2024.106286.
      PubMed         Abstract available
    23. VEGA-PIRIS L, Carretero SG, Mayordomo JL, Zarzuelo MBR, et al
      Severity of Respiratory Syncytial Virus compared with SARS-CoV-2 and Influenza among hospitalised adults >/=65 years.
      J Infect. 2024 Sep 26:106292. doi: 10.1016/j.jinf.2024.106292.
      PubMed         Abstract available
    24. CHEN X, Balliew J, Bauer CX, Deegan J, et al
      Revealing patterns of SARS-CoV-2 variant emergence and evolution using RBD amplicon sequencing of wastewater.
      J Infect. 2024 Sep 26:106284. doi: 10.1016/j.jinf.2024.106284.
      PubMed         Abstract available
    25. RABDANO SO, Ruzanova EA, Vertyachikh AE, Teplykh VA, et al
      N-protein vaccine is effective against COVID-19: phase 3, randomized, double-blind, placebo-controlled clinical trial.
      J Infect. 2024 Sep 26:106288. doi: 10.1016/j.jinf.2024.106288.
      PubMed         Abstract available
    26. SABATE-ELABBADI A, Brolon L, Brun-Buisson C, Guillemot D, et al
      Trends in hospitalisations for lower respiratory infections after the COVID-19 pandemic in France.
      J Infect. 2024 Sep 26:106287. doi: 10.1016/j.jinf.2024.106287.
      PubMed         Abstract available

      J Med Virol

    27. KUHN D, Heinen N, Sutter K, Herrmann ST, et al
      Divergent autoantibody and cytokine levels in COVID-19 sepsis patients influence survival.
      J Med Virol. 2024;96:e29935.
      PubMed         Abstract available
    28. LOVELL JF, Miura K, Baik YO, Lee C, et al
      Interim safety and immunogenicity analysis of the EuCorVac-19 COVID-19 vaccine in a Phase 3 randomized, observer-blind, immunobridging trial in the Philippines.
      J Med Virol. 2024;96:e29927.
      PubMed         Abstract available
    29. LI H, Yang Y, Tao R, Shang S, et al
      Analyzing infections caused by 11 respiratory pathogens in children: Pre- and post-COVID-19 pandemic trends in China.
      J Med Virol. 2024;96:e29929.
      PubMed         Abstract available
    30. HORI M, Hayama-Terada M, Kitamura A, Hosozawa M, et al
      Risk factors for post-coronavirus disease condition in the Alpha-, Delta-, and Omicron-dominant waves among adults in Japan: A population-based matched case-control study.
      J Med Virol. 2024;96:e29928.
      PubMed         Abstract available

      J Virol

    31. KANG JS, Zhou K, Wang H, Tang S, et al
      Architectural organization and in situ fusion protein structure of lymphocytic choriomeningitis virus.
      J Virol. 2024 Sep 27:e0064024. doi: 10.1128/jvi.00640.
      PubMed         Abstract available

      JAMA

    32. ANDERER S
      Caseload Strain Contributed to 1 in 5 COVID-19 Deaths at US Hospitals.
      JAMA. 2024 Sep 27. doi: 10.1001/jama.2024.19687.
      PubMed        

      Lancet

    33. IMANI-MUSIMWA P, Ververs M
      Mpox and breastmilk: for once, can we act in time?
      Lancet. 2024 Sep 13:S0140-6736(24)01881-6. doi: 10.1016/S0140-6736(24)01881.
      PubMed        
    34. HORTON R
      Offline: Xenotransplantation-a new era beckons.
      Lancet. 2024;404:1181.
      PubMed        
    35. ROMANELLO M, Costello A
      The Lancet Countdown on health and climate change: competing interests and optimism bias – Authors’ reply.
      Lancet. 2024;404:1197-1198.
      PubMed        
    36. BRINK N, Chersich MF
      The Lancet Countdown on health and climate change: competing interests and optimism bias.
      Lancet. 2024;404:1196.
      PubMed        
    37. BUTLER CD, Combs Bowles D, Hanigan IC, Harmer A, et al
      The Lancet Countdown on health and climate change: competing interests and optimism bias.
      Lancet. 2024;404:1196-1197.
      PubMed        
    38. ROMANELLO M, Beggs PJ, Cai W, Gordon-Strachan G, et al
      The Lancet Countdown on health and climate change: representation matters – Authors’ reply.
      Lancet. 2024;404:1195-1196.
      PubMed        
    39. STREET R, Wright CY
      The Lancet Countdown on health and climate change: representation matters.
      Lancet. 2024;404:1194.
      PubMed        

      Lancet Infect Dis

    40. DAS M
      Understanding outbreak preparedness.
      Lancet Infect Dis. 2024;24:1079.
      PubMed        
    41. OLBRICH L, Franckling-Smith Z, Larsson L, Sabi I, et al
      Sequential and parallel testing for microbiological confirmation of tuberculosis disease in children in five low-income and middle-income countries: a secondary analysis of the RaPaed-TB study.
      Lancet Infect Dis. 2024 Sep 20:S1473-3099(24)00494.
      PubMed         Abstract available
    42. LAWSON M
      Globalisation and COVID-19.
      Lancet Infect Dis. 2024 Sep 20:S1473-3099(24)00621.
      PubMed        
    43. TERSTAPPEN J, Hak SF, Bhan A, Bogaert D, et al
      The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access.
      Lancet Infect Dis. 2024 Sep 23:S1473-3099(24)00455.
      PubMed         Abstract available
    44. FIGUEROA AL, Torres D, Reyes-Acuna C, Matherne P, et al
      Safety and immunogenicity of a single-dose omicron-containing COVID-19 vaccination in adolescents: an open-label, single-arm, phase 2/3 trial.
      Lancet Infect Dis. 2024 Sep 24:S1473-3099(24)00501.
      PubMed         Abstract available
    45. WANG WX, Zhu FC
      COVID-19 immunisation strategies for adolescents.
      Lancet Infect Dis. 2024 Sep 24:S1473-3099(24)00563.
      PubMed        
    46. HAPPLE C, Hoffmann M, Kempf A, Nehlmeier I, et al
      Humoral immunity after mRNA SARS-CoV-2 omicron JN.1 vaccination.
      Lancet Infect Dis. 2024 Sep 25:S1473-3099(24)00603.
      PubMed        

      MMWR Morb Mortal Wkly Rep

    47. HAVERS FP, Whitaker M, Chatwani B, Patton ME, et al
      COVID-19-Associated Hospitalizations and Maternal Vaccination Among Infants Aged <6 Months – COVID-NET, 12 States, October 2022-April 2024.
      MMWR Morb Mortal Wkly Rep. 2024;73:830-836.
      PubMed         Abstract available
    48. HILL HA, Yankey D, Elam-Evans LD, Mu Y, et al
      Decline in Vaccination Coverage by Age 24 Months and Vaccination Inequities Among Children Born in 2020 and 2021 – National Immunization Survey-Child, United States, 2021-2023.
      MMWR Morb Mortal Wkly Rep. 2024;73:844-853.
      PubMed         Abstract available

      Nature

    49. The youngest among us fight COVID-19 in their own way.
      Nature. 2024 Sep 24. doi: 10.1038/d41586-024-03091.
      PubMed   

    https://etidioh.wordpress.com/2024/09/29/coronavirus-disease-research-references-amedeo-september-29-24/

    #betacoronavirus #covid #COVID19 #health #pandemic #research #sarbecovirus #sarsCov2 #vaccine

    #betacoronavirus #covid #covid19 #health #pandemic #research
  24. ETIDIoH @[email protected] ·
    1. June 1 Highlight.
      Am J Respir Crit Care Med. 2024;209:xxxvii-xxxviii.
      PubMed        

      BMJ

    2. REYNOLDS C, Naqvi H
      Better use of data can help to prevent future deaths.
      BMJ. 2024;385:q1181.
      PubMed        
    3. LYNN E
      May top picks: politics, psychological safety, and creativity.
      BMJ. 2024;385:q1166.
      PubMed        
    4. TAYLOR L
      Pandemic treaty: panel calls for “reset” to talks as negotiators miss deadline.
      BMJ. 2024;385:q1193.
      PubMed        
    5. LIMB M
      Labour’s pledge to clear NHS waiting list within five years will be tough to achieve, say leaders.
      BMJ. 2024;385:q1186.
      PubMed        
    6. KMIETOWICZ Z
      Junior doctors in England announce five day walkout ahead of general election.
      BMJ. 2024;385:q1183.
      PubMed        
    7. MAHASE E
      GPs could threaten mass resignation over NHS contract.
      BMJ. 2024;385:q1182.
      PubMed        
    8. WISE J
      Improving infection prevention could avoid 750 000 deaths a year, say experts.
      BMJ. 2024;385:q1163.
      PubMed        
    9. DYER O
      Covid-19: South African disclosures reveal secretive world of nations’ vaccine contracts.
      BMJ. 2024;385:q1172.
      PubMed        

      Clin Infect Dis

    10. WOLFE DN, Arangies E, David GL, Armstrong B, et al
      Development of Next-Generation COVID-19 Vaccines: BARDA Supported Phase 2b Study Designs.
      Clin Infect Dis. 2024 May 28:ciae286. doi: 10.1093.
      PubMed         Abstract available
    11. HILL JA, Martens MJ, Young JH, Bhavsar K, et al
      SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study.
      Clin Infect Dis. 2024 May 27:ciae291. doi: 10.1093.
      PubMed         Abstract available

      Int J Infect Dis

    12. REEKIE J, Stovring H, Nielsen H, Johansen IS, et al
      Development of antibody levels and subsequent decline in individuals with vaccine induced and hybrid immunity to SARS-CoV-2.
      Int J Infect Dis. 2024 May 25:107111. doi: 10.1016/j.ijid.2024.107111.
      PubMed         Abstract available

      Intensive Care Med

    13. OUD L
      Long-term outcomes of critically ill patients with hematological malignancies: what is the impact of the coronavirus disease 2019 pandemic?
      Intensive Care Med. 2024 May 28. doi: 10.1007/s00134-024-07493.
      PubMed        

      J Med Virol

    14. HAN Y, Ma Y, Wang Z, Feng F, et al
      TMPRSS13 promotes the cell entry of swine acute diarrhea syndrome coronavirus.
      J Med Virol. 2024;96:e29712.
      PubMed         Abstract available
    15. BORGOGNA C, Ferrante D, Rosso G, Guglielmetti G, et al
      A prospective humoral immune monitoring study of kidney transplant recipients receiving three doses of SARS-CoV-2 mRNA vaccine.
      J Med Virol. 2024;96:e29710.
      PubMed         Abstract available
    16. PAVIA G, Quirino A, Marascio N, Veneziano C, et al
      Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients.
      J Med Virol. 2024;96:e29708.
      PubMed         Abstract available
    17. KOW CS, Ramachandram DS, Hasan SS, Thiruchelvam K, et al
      Antibiotics in COVID-19: Unveiling disturbing truths through critical scrutiny.
      J Med Virol. 2024;96:e29720.
      PubMed        
    18. CHEN IW, Yu TS, Lin CH, Hung KC, et al
      Effectiveness of nirmatrelvir-ritonavir on severe outcomes of COVID-19: A meta-regression analysis.
      J Med Virol. 2024;96:e29718.
      PubMed        

      J Travel Med

    19. TAY M, Lee B, Ismail MH, Yam J, et al
      Usefulness of aircraft and airport wastewater for monitoring multiple pathogens including SARS-CoV-2 variants.
      J Travel Med. 2024 May 30:taae074. doi: 10.1093.
      PubMed         Abstract available

      J Virol

    20. MARIZZI C, Ajayi PK, McMahon R, Meade PS, et al
      A community science approach to public health and public trust in science.
      J Virol. 2024 May 29:e0082524. doi: 10.1128/jvi.00825.
      PubMed         Abstract available
    21. RAHMAN SM, Buchholz DW, Imbiakha B, Jager MC, et al
      Migraine inhibitor olcegepant reduces weight loss and IL-6 release in SARS-CoV-2-infected older mice with neurological signs.
      J Virol. 2024 May 30:e0006624. doi: 10.1128/jvi.00066.
      PubMed         Abstract available
    22. KARMAKAR S, Das Sarma J
      Human coronavirus OC43 infection remodels connexin 43-mediated gap junction intercellular communication in vitro.
      J Virol. 2024 May 31:e0047824. doi: 10.1128/jvi.00478.
      PubMed         Abstract available

      Lancet

    23. THORNTON J
      Infected blood report release marks a day of shame for the UK.
      Lancet. 2024;403:2276-2277.
      PubMed        
    24. LAXMINARAYAN R, Impalli I, Rangarajan R, Cohn J, et al
      Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance.
      Lancet. 2024 May 20:S0140-6736(24)00878-X. doi: 10.1016/S0140-6736(24)00878.
      PubMed         Abstract available
    25. THE LANCET
      Cyberattacks on health care-a growing threat.
      Lancet. 2024;403:2263.
      PubMed        
    26. KIMBALL AB, Jemec GBE, Sayed CJ, Kirby JS, et al
      Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials.
      Lancet. 2024 May 22:S0140-6736(24)00101-6. doi: 10.1016/S0140-6736(24)00101.
      PubMed         Abstract available
    27. PATERLINI M
      Warnings over Italian health-care devolution.
      Lancet. 2024;403:2279.
      PubMed        

      Lancet Infect Dis

    28. HALL P
      Highlights of ESCMID Global 2024.
      Lancet Infect Dis. 2024;24:e357.
      PubMed        
    29. VENKATESAN P
      Alasdair Macintosh Geddes.
      Lancet Infect Dis. 2024;24:577.
      PubMed        

      Life Sci

    30. PETRY J, Weiser T, Griesbaum L, Schroder K, et al
      1.8-cineole prevents platelet activation and aggregation by activating the cAMP pathway via the adenosine A(2A) receptor.
      Life Sci. 2024 May 27:122746. doi: 10.1016/j.lfs.2024.122746.
      PubMed         Abstract available

      N Engl J Med

    31. WANG JJ, Schonborn L, Warkentin TE, Chataway T, et al
      Antibody Fingerprints Linking Adenoviral Anti-PF4 Disorders.
      N Engl J Med. 2024;390:1827-1829.
      PubMed        
    32. HALABI S, Gostin LO, Egbokhare O, Kavanagh MM, et al
      Global Health Law for a Safer and Fairer World.
      N Engl J Med. 2024;390:1925-1931.
      PubMed        

      Nature

    33. HAN Y, Duan X, Yang L, Nilsson-Payant BE, et al
      Author Correction: Identification of SARS-CoV-2 inhibitors using lung and colonic organoids.
      Nature. 2024 May 29. doi: 10.1038/s41586-024-07593.
      PubMed        

      Science

    34. VAN DER LINDEN S, Kyrychenko Y
      A broader view of misinformation reveals potential for intervention.
      Science. 2024;384:959-960.
      PubMed         Abstract available
    35. ALLEN J, Watts DJ, Rand DG
      Quantifying the impact of misinformation and vaccine-skeptical content on Facebook.
      Science. 2024;384:eadk3451.
      PubMed         Abstract available

    https://etidioh.wordpress.com/2024/06/01/coronavirus-disease-research-references-by-amedeo-june-1-24/

    #betacoronavirus #coronavirus #COVID19 #exercise #health #mentalHealth #nutrition #research #sarbecovirus #sarsCov2 #wellness

    #betacoronavirus #coronavirus #covid19 #exercise #health #mentalhealth
  25. ETIDIoH @[email protected] ·
    1. MELLO MM, Jiang D, Platt E, Moran-McCabe K, et al.
      Legal infrastructure for pandemic response: lessons not learnt in the US.
      BMJ. 2024;384:e076269.
      PubMed: https://www.amedeo.com/p2.php?id=38346813&s=cov&pm=2
       
      Share: https://m.amedeo.com/38346813
    2. Seven days in medicine: 31 Jan to 6 Feb 2024.
      BMJ. 2024;384:q299.
      PubMed: https://www.amedeo.com/p2.php?id=38331441&s=cov&pm=2
       
      Share: https://m.amedeo.com/38331441
    3. IACOBUCCI G.
      Long covid: Online rehabilitation can improve quality of life, study reports.
      BMJ. 2024;384:q346.
      PubMed: https://www.amedeo.com/p2.php?id=38331437&s=cov&pm=2
       
      Share: https://m.amedeo.com/38331437
    4. COLSON P, Delerce J, Pontarotti P, Devaux C, et al.
      Resistance-associated mutations to the anti-SARS-CoV-2 agent nirmatrelvir:
      Selection not induction.
      J Med Virol. 2024;96:e29462.
      PubMed: https://www.amedeo.com/p2.php?id=38363015&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38363015
    5. SADAT LARIJANI M, Javadi A, Eskandari SE, Doroud D, et al.
      The impact of ABO blood types on humoral immunity responses and antibody
      persistency after different COVID-19 vaccine regimens.
      J Med Virol. 2024;96:e29438.
      PubMed: https://www.amedeo.com/p2.php?id=38353517&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38353517
    6. CENAT JM, Farahi SMMM, Dalexis RD, Yaya S, et al.
      COVID-19 vaccine uptake, conspiracy theories, and health literacy among Black
      individuals in Canada: Racial discrimination, confidence in health, and COVID-19
      stress as mediators.
      J Med Virol. 2024;96:e29467.
      PubMed: https://www.amedeo.com/p2.php?id=38348886&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38348886
    7. KWOK KO, Wei WI, Mcneil EB, Tang A, et al.
      Comparative analysis of symptom profile and risk of death associated with
      infection by SARS-CoV-2 and its variants in Hong Kong.
      J Med Virol. 2024;96:e29326.
      PubMed: https://www.amedeo.com/p2.php?id=38345166&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38345166
    8. KIM D, Kim M, Kim J, Baek K, et al.
      A mouse xenograft long-term replication yields a SARS-CoV-2 Delta mutant with
      increased lethality.
      J Med Virol. 2024;96:e29459.
      PubMed: https://www.amedeo.com/p2.php?id=38345153&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38345153
    9. ZHAN H, Xie Y, Liu Y, Cheng L, et al.
      Omicron BA.4/5 neutralization and cell-mediated immune responses in relation to
      baseline immune status and breakthrough infection among PLWH: A follow-up cohort
      study.
      J Med Virol. 2024;96:e29446.
      PubMed: https://www.amedeo.com/p2.php?id=38345110&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38345110
    10. ZENG G, Zhang Z, Wang L, Li J, et al.
      Risk factors of long COVID 6-12 months after infection with the Omicron variant
      among nonhospitalized patients.
      J Med Virol. 2023;95:e29235.
      PubMed: https://www.amedeo.com/p2.php?id=37970745&s=cov&pm=2
       
      Share: https://m.amedeo.com/37970745
    11. LI Z, Lai Y, Qiu R, Tang W, et al.
      Hyperacetylated microtubules assist porcine deltacoronavirus nsp8 to degrade MDA5
      via SQSTM1/p62-dependent selective autophagy.
      J Virol. 2024 Feb 14:e0000324. doi: 10.1128/jvi.00003.
      PubMed: https://www.amedeo.com/p2.php?id=38353538&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38353538
    12. RUBIN R.
      When It Comes to SARS-CoV-2 Clearance, People Who are Immunocompromised Are Not
      All Alike.
      JAMA. 2024 Feb 14. doi: 10.1001/jama.2024.1014.
      PubMed: https://www.amedeo.com/p2.php?id=38353960&s=cov&pm=2
       
      Share: https://m.amedeo.com/38353960
    13. WALLER BY, Joseph VA, Keyes KM.
      Racial inequities in homicide rates and homicide methods among Black and White
      women aged 25-44 years in the USA, 1999-2020: a cross-sectional time series
      study.
      Lancet. 2024 Feb 8:S0140-6736(23)02279-1. doi: 10.1016/S0140-6736(23)02279.
      PubMed: https://www.amedeo.com/p2.php?id=38342127&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38342127
    14. VERMERSCH P, Granziera C, Mao-Draayer Y, Cutter G, et al.
      Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
      N Engl J Med. 2024;390:589-600.
      PubMed: https://www.amedeo.com/p2.php?id=38354138&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38354138
    15. The immune markers that predict who can keep SARS-CoV-2 in check.
      Nature. 2024 Feb 13. doi: 10.1038/d41586-024-00411.
      PubMed: https://www.amedeo.com/p2.php?id=38351161&s=cov&pm=2
       
      Share: https://m.amedeo.com/38351161
    16. GAGLIARDINI R, Giacomelli A, Bozzi G, D’Arminio Monforte A, et al.
      Impact of COVID-19 pandemic on retention in care of native and migrant people
      with HIV in the ICONA cohort.
      Travel Med Infect Dis. 2024;58:102691.
      PubMed: https://www.amedeo.com/p2.php?id=38336335&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38336335
    17. HOFMEYER KA, Ventura CL, Armstrong KL, Houchens CR, et al.
      Project NexGen: Developing the Next Generation of COVID-19 Vaccines and
      Therapeutics to Respond to the Present and Prepare for the Future.
      Clin Infect Dis. 2024 Feb 13:ciae073. doi: 10.1093.
      PubMed: https://www.amedeo.com/p2.php?id=38356144&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38356144
    18. MACHKOVECH HM, Hahn AM, Garonzik Wang J, Grubaugh ND, et al.
      Persistent SARS-CoV-2 infection: significance and implications.
      Lancet Infect Dis. 2024 Feb 7:S1473-3099(23)00815.
      PubMed: https://www.amedeo.com/p2.php?id=38340735&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38340735
    19. JIAO Z, Wang P, Hu X, Chen Y, et al.
      Feline infectious peritonitis virus ORF7a is a virulence factor involved in
      inflammatory pathology in cats.
      Antiviral Res. 2024;222:105794.
      PubMed: https://www.amedeo.com/p2.php?id=38176470&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38176470

    https://etidioh.wordpress.com/2024/02/18/coronavirus-disease-research-references-by-amedeo-february-18-24/

    #betacoronavirus #coronavirus #covid #COVID19 #health #research #sarbecovirus #sarsCov2 #science

    #betacoronavirus #coronavirus #covid #covid19 #health #research
  26. Giuseppe Michieli @[email protected] ·

    #Betacoronavirus #Infection #Outbreak, São Paulo, #Brazil Fall 2023, Emerg Infect Dis. wwwnc.cdc.gov/eid/article/30/3

    -- We report a #human CoV #OC43 infection #outbreak in hospitalized patients and #HCWs in São Paulo, Brazil, occurring after SARS-CoV-2 cases disappeared. Infection was associated with HCWs in 5 (29.4%) patients. Routine surveillance including a respiratory virus panel can improve coronavirus detection in both healthcare professionals and patients.

    #betacoronavirus #infection #outbreak #brazil #human #oc43
  27. ETIDIoH @[email protected] ·
    1. BOUZIDI HS, Driouich JS, Klitting R, Bernadin O, et al
      Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains.
      Antiviral Res. 2024 Jan 23:105814. doi: 10.1016/j.antiviral.2024.105814.
      PubMed         Abstract available
    2. BOGACHEVA MS, Kuivanen S, Potdar S, Hassinen A, et al
      Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome.
      Antiviral Res. 2024 Jan 23:105813. doi: 10.1016/j.antiviral.2024.105813.
      PubMed         Abstract available
    3. BOND ACS, Crocker MA, Wilczek MP, DuShane JK, et al
      High-throughput drug screen identifies calcium and calmodulin inhibitors that reduce JCPyV infection.
      Antiviral Res. 2024 Jan 19:105817. doi: 10.1016/j.antiviral.2024.105817.
      PubMed         Abstract available
    4. IDRIS A, Supramaniam A, Tayyar Y, Kelly G, et al
      An intranasally delivered ultra-conserved siRNA prophylactically represses SARS-CoV-2 infection in the lung and nasal cavity.
      Antiviral Res. 2024;222:105815.
      PubMed         Abstract available

      BMJ

    5. WATERS A
      Covid-19: Doctors instruct law firm in bid for compensation after developing long covid.
      BMJ. 2024;384:q188.
      PubMed        
    6. BRINDLEY P
      Essential workers during covid-19: how quickly we forget.
      BMJ. 2024;384:q179.
      PubMed        
    7. WISE J
      UK covid inquiry: Scotland’s infection control and care home policies face scrutiny.
      BMJ. 2024;384:q162.
      PubMed        

      Clin Infect Dis

    8. RYBOLT L, Oehler RL, Khalil FK, Khalil B, et al
      A 22-Year-Old With a Left Apical Chest Mass.
      Clin Infect Dis. 2024;78:199-201.
      PubMed        
    9. HSUEH K, Teherani A, Guzman-Cottrill JA
      The Leaders in Epidemiology, Antimicrobial Stewardship, and Public Health (LEAP) Fellowship, a Novel Training Program in Public Health for Infectious Diseases Physicians.
      Clin Infect Dis. 2024 Jan 24:ciad787. doi: 10.1093.
      PubMed         Abstract available

      Emerg Infect Dis

    10. JUSTMAN J, Skalland T, Moore A, Amos CI, et al
      Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021(1).
      Emerg Infect Dis. 2024;30:245-254.
      PubMed         Abstract available
    11. PORTER SM, Hartwig AE, Bielefeldt-Ohmann H, Marano JM, et al
      Experimental SARS-CoV-2 Infection of Elk and Mule Deer.
      Emerg Infect Dis. 2024;30:354-357.
      PubMed         Abstract available
    12. TORI ME, Chontos-Komorowski J, Stacy J, Lamson DM, et al
      Identification of Large Adenovirus Infection Outbreak at University by Multipathogen Testing, South Carolina, USA, 2022.
      Emerg Infect Dis. 2024;30:358-362.
      PubMed         Abstract available
    13. TAKEMURA T, Ankhanbaatar U, Settypalli TBK, Purevtseren D, et al
      SARS-CoV-2 Infection in Beaver Farm, Mongolia, 2021.
      Emerg Infect Dis. 2024;30:391-394.
      PubMed         Abstract available
    14. HODGES NF, Sparrer M, Sherman T, Mayer T, et al
      Integrating Veterinary Diagnostic Laboratories for Emergency Use Testing during Pandemics(1).
      Emerg Infect Dis. 2024;30:386-388.
      PubMed         Abstract available

      J Infect

    15. LIU Y, Sun R, Zhang H, Huang J, et al
      Trends and predictions of tuberculosis notification in mainland China during and after the COVID-19 pandemic.
      J Infect. 2023;87:e100-e103.
      PubMed        
    16. AO G, Li T, Nasr B, Wang Y, et al
      The effect of dupilumab on clinical outcomes in patients with COVID-19: A meta-analysis.
      J Infect. 2023;87:e107-e109.
      PubMed        
    17. MURRAY JM, Murray DD, Schvoerer E, Akand EH, et al
      SARS-CoV-2 Delta and Omicron community transmission networks as added value to contact tracing.
      J Infect. 2024 Jan 17:S0163-4453(24)00023-9. doi: 10.1016/j.jinf.2024.
      PubMed         Abstract available

      J Med Virol

    18. YANG X, Wang Y, Liang Z, Cui T, et al
      Immune escape of BA.2.86 is comparable to XBB subvariants from the plasma of BA.5- and BA.5-XBB-convalescent subpopulations.
      J Med Virol. 2024;96:e29417.
      PubMed         Abstract available
    19. ZHANG T, Magazine N, McGee MC, Carossino M, et al
      Th2 and Th17-associated immunopathology following SARS-CoV-2 breakthrough infection in Spike-vaccinated ACE2-humanized mice.
      J Med Virol. 2024;96:e29408.
      PubMed         Abstract available
    20. JIA J, Garbarino E, Wang Y, Li J, et al
      Generation of SARS-CoV-2 spike receptor binding domain mutants and functional screening for immune evaders using a novel lentivirus-based system.
      J Med Virol. 2024;96:e29425.
      PubMed         Abstract available
    21. SUN Y, Zhou J, Nie W, Tian D, et al
      Study on the epidemiological characteristics of enterovirus among pediatric patients in Hangzhou, China: A comparison between the pre-COVID-19, COVID-19 pandemic, and post-COVID-19 periods.
      J Med Virol. 2024;96:e29412.
      PubMed         Abstract available

      J Travel Med

    22. CHIU NC, Chi H, Weng SL, Lin CY, et al
      Unprecedented dengue outbreak in Taiwan following COVID-19.
      J Travel Med. 2024 Jan 21:taae015. doi: 10.1093.
      PubMed        
    23. SOHAIL A, Anders KL, McGuinness SL, Leder K, et al
      The epidemiology of imported and locally-acquired dengue in Australia, 2012-2022.
      J Travel Med. 2024 Jan 18:taae014. doi: 10.1093.
      PubMed         Abstract available

      J Virol

    24. DEY S, Mondal A
      Unveiling the role of host kinases at different steps of influenza A virus life cycle.
      J Virol. 2024 Jan 4:e0119223. doi: 10.1128/jvi.01192.
      PubMed         Abstract available
    25. ZHANG S, Wang J, Liu X, Kan Z, et al
      Pemetrexed alleviates piglet diarrhea by blocking the interaction between porcine epidemic diarrhea virus nucleocapsid protein and Ezrin.
      J Virol. 2024;98:e0162523.
      PubMed         Abstract available

      Lancet

    26. MCCLOSKEY B, Saito T, Shimada S, Ikenoue C, et al
      The Tokyo 2020 and Beijing 2022 Olympic Games held during the COVID-19 pandemic: planning, outcomes, and lessons learnt.
      Lancet. 2024 Jan 17:S0140-6736(23)02635-1. doi: 10.1016/S0140-6736(23)02635.
      PubMed         Abstract available

      MMWR Morb Mortal Wkly Rep

    27. MONACH PA, Anand ST, Fillmore NR, La J, et al
      Underuse of Antiviral Drugs to Prevent Progression to Severe COVID-19 – Veterans Health Administration, March-September 2022.
      MMWR Morb Mortal Wkly Rep. 2024;73:57-61.
      PubMed         Abstract available

      N Engl J Med

    28. BORGHESI A, Casanova JL
      Convalescent Plasma for Covid-19-Induced ARDS.
      N Engl J Med. 2024;390:384-385.
      PubMed        
    29. SENEFELD JW, Henderson JP, Joyner MJ
      Convalescent Plasma for Covid-19-Induced ARDS.
      N Engl J Med. 2024;390:385.
      PubMed        
    30. CASADEVALL A, Shoham S, Pirofski LA
      Convalescent Plasma for Covid-19-Induced ARDS.
      N Engl J Med. 2024;390:385-386.
      PubMed        
    31. MISSET B, Desmecht D, Laterre PF
      Convalescent Plasma for Covid-19-Induced ARDS. Reply.
      N Engl J Med. 2024;390:386.
      PubMed        

      Radiology

    32. LEE JE, Jin KN, Hong H, Jeong YJ, et al
      Effectiveness of COVID-19 Vaccines Over Time Against Clinical and Radiologic Outcomes Related to Severe SARS-CoV-2 Infection.
      Radiology. 2024;310:e231928.
      PubMed         Abstract available
    33. WELLS AU
      COVID-19 Vaccine Efficacy Over Time: Severe Disease in Hospitalized Patients.
      Radiology. 2024;310:e233340.
      PubMed        

      Science

    34. RUF W
      Immune damage in Long Covid.
      Science. 2024;383:262-263.
      PubMed         Abstract available
    35. LESLIE M
      SARS-CoV-2 sneezing explained.
      Science. 2024;383:354.
      PubMed         Abstract available

    https://etidioh.wordpress.com/2024/01/29/coronavirus-disease-research-references-by-amedeo-january-29-24/

    #betacoronavirus #coronavirus #covid #COVID19 #health #research #sarbecovirus #sarsCov2 #science

    #betacoronavirus #coronavirus #covid #covid19 #health #research
  28. ETIDIoH @[email protected] ·
    1. KERCHBERGER VE.
      Host Response to Infection: Not All Lymphopenia Is Created Equal in SARS-CoV-2.
      Am J Respir Crit Care Med. 2024 Jan 8. doi: 10.1164/rccm.202312-2265.
      PubMed: https://www.amedeo.com/p2.php?id=38190496&s=cov&pm=2
       
      Share: https://m.amedeo.com/38190496
    2. WU Q, Tong J, Zhang B, Zhang D, et al.
      Real-World Effectiveness of BNT162b2 Against Infection and Severe Diseases in Children and Adolescents.
      Ann Intern Med. 2024 Jan 9. doi: 10.7326/M23-1754.
      PubMed: https://www.amedeo.com/p2.php?id=38190711&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38190711
    3. O’DOWD A.
      Covid-19 has cut UK life expectancy by around half a year, data suggest.
      BMJ. 2024;384:q78.
      PubMed: https://www.amedeo.com/p2.php?id=38216221&s=cov&pm=2
       
      Share: https://m.amedeo.com/38216221
    4. MAHASE E.
      Covid-19: NICE plans to expand Paxlovid eligibility to 1.4 million more people.
      BMJ. 2024;384:q59.
      PubMed: https://www.amedeo.com/p2.php?id=38212056&s=cov&pm=2
       
      Share: https://m.amedeo.com/38212056
    5. Update to living systematic review on SARS-CoV-2 positivity in offspring and timing of mother-to-child transmission.
      BMJ. 2024;384:p2929.
      PubMed: https://www.amedeo.com/p2.php?id=38199645&s=cov&pm=2
       
      Share: https://m.amedeo.com/38199645
    6. SLAUNWHITE A, Min JE, Palis H, Urbanoski K, et al.
      Effect of Risk Mitigation Guidance opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study.
      BMJ. 2024;384:e076336.
      PubMed: https://www.amedeo.com/p2.php?id=38199614&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38199614
    7. TANNE JH.
      Covid-19: Some US states and hospitals recommend masks again.
      BMJ. 2024;384:q26.
      PubMed: https://www.amedeo.com/p2.php?id=38182176&s=cov&pm=2
       
      Share: https://m.amedeo.com/38182176
    8. EGBELOWO OF, Fox SJ, Gibson GC, Meyers LA, et al.
      Model for Interpreting Discordant SARS-CoV-2 Diagnostic Test Results.
      Emerg Infect Dis. 2024;30.
      PubMed: https://www.amedeo.com/p2.php?id=38217064&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38217064
    9. EALES O, Plank MJ, Cowling BJ, Howden BP, et al.
      Key Challenges for Respiratory Virus Surveillance while Transitioning out of Acute Phase of COVID-19 Pandemic.
      Emerg Infect Dis. 2024;30.
      PubMed: https://www.amedeo.com/p2.php?id=38190760&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38190760
    10. JEON S, Watson-Lewis L, Rainisch G, Chiu CC, et al.
      Adapting COVID-19 Contact Tracing Protocols to Accommodate Resource Constraints, Philadelphia, Pennsylvania, USA, 2021.
      Emerg Infect Dis. 2024;30.
      PubMed: https://www.amedeo.com/p2.php?id=38181801&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38181801
    11. BAI Y, Du Z, Wang L, Lau EHY, et al.
      Public Health Impact of Paxlovid as Treatment for COVID-19, United States.
      Emerg Infect Dis. 2024;30.
      PubMed: https://www.amedeo.com/p2.php?id=38181800&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38181800
    12. HU L, Yang Y, Lin J, Yan Q, et al.
      Epidemiological characteristics of respiratory syncytial virus infection in pediatric patients before, during the COVID-19 pandemic and after easing of COVID-19 restrictive measures in China.
      J Med Virol. 2024;96:e29374.
      PubMed: https://www.amedeo.com/p2.php?id=38197487&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38197487
    13. ZHANG Y, Ma Y, Sun W, Zhou X, et al.
      Exploring gut-lung axis crosstalk in SARS-CoV-2 infection: Insights from a hACE2 mouse model.
      J Med Virol. 2024;96:e29336.
      PubMed: https://www.amedeo.com/p2.php?id=38193530&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38193530
    14. FAVRESSE J, Gillot C, Closset M, Cabo J, et al.
      Durability of humoral and cellular immunity six months after the BNT162b2 bivalent booster.
      J Med Virol. 2024;96:e29365.
      PubMed: https://www.amedeo.com/p2.php?id=38185981&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38185981
    15. CHOI CY, Gadhave K, Villano J, Pekosz A, et al.
      Generation and characterization of a humanized ACE2 mouse model to study long-term impacts of SARS-CoV-2 infection.
      J Med Virol. 2024;96:e29349.
      PubMed: https://www.amedeo.com/p2.php?id=38185937&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38185937
    16. LEE HM, Shih PC, Wei JC.
      Comment on Shao et al.’s “Risk factors associated with COVID-19 pneumonia in Chinese patients with pre-existing interstitial lung disease during the SARS-CoV-2 pandemic”.
      J Med Virol. 2024;96:e29383.
      PubMed: https://www.amedeo.com/p2.php?id=38180246&s=cov&pm=2
       
      Share: https://m.amedeo.com/38180246
    17. LI J, Zhang K, Lin G, Li J, et al.
      CRISPR-Cas system: A promising tool for rapid detection of SARS-CoV-2 variants.
      J Med Virol. 2024;96:e29356.
      PubMed: https://www.amedeo.com/p2.php?id=38180237&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38180237
    18. CAPELLI N, Domitien Payet L, Alcocer Cordellat C, Pisoni A, et al.
      SARS-CoV-2 nucleocapsid antigen in plasma of children hospitalized for COVID-19 or with incidental detection of SARS-CoV-2 infection.
      J Med Virol. 2024;96:e29358.
      PubMed: https://www.amedeo.com/p2.php?id=38180230&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38180230
    19. MOORE JE, Millar BC.
      Improving health literacy of passengers of cruise ships: readability of passenger-facing COVID-19 information provided by commercial cruise lines-an infodemiology study.
      J Travel Med. 2024 Jan 11:taae006. doi: 10.1093.
      PubMed: https://www.amedeo.com/p2.php?id=38206876&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38206876
    20. JAMES ER, Church LWP, Hoffman SL, Robertson BD, et al.
      Piloting delivery of PfSPZ vaccines for malaria through a cryogenic vaccine cold chain to travel and military medicine clinics.
      J Travel Med. 2024 Jan 11:taae007. doi: 10.1093.
      PubMed: https://www.amedeo.com/p2.php?id=38206875&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38206875
    21. DULIN H, Barre RS, Xu D, Neal A, et al.
      Harnessing preexisting influenza virus-specific immunity increases antibody responses against SARS-CoV-2.
      J Virol. 2024 Jan 11:e0157123. doi: 10.1128/jvi.01571.
      PubMed: https://www.amedeo.com/p2.php?id=38206036&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38206036
    22. BERTZBACH LD, Seddar L, von Stromberg K, Ip W-H, et al.
      The adenovirus DNA-binding protein DBP.
      J Virol. 2024 Jan 10:e0188523. doi: 10.1128/jvi.01885.
      PubMed: https://www.amedeo.com/p2.php?id=38197632&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38197632
    23. YIN L, Liu X, Yao Y, Yuan M, et al.
      Gut microbiota-derived butyrate promotes coronavirus TGEV infection through impairing RIG-I-triggered local type I interferon responses via class I HDAC inhibition.
      J Virol. 2024 Jan 10:e0137723. doi: 10.1128/jvi.01377.
      PubMed: https://www.amedeo.com/p2.php?id=38197629&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38197629
    24. RUBIN R.
      As COVID-19 Cases Surge, Here’s What to Know About JN.1, the Latest SARS-CoV-2 “Variant of Interest”.
      JAMA. 2024 Jan 12. doi: 10.1001/jama.2023.27841.
      PubMed: https://www.amedeo.com/p2.php?id=38214935&s=cov&pm=2
       
      Share: https://m.amedeo.com/38214935
    25. RUBIN R.
      From “Immunity Debt” to “Immunity Theft”-How COVID-19 Might Be Tied to Recent Respiratory Disease Surges.
      JAMA. 2024 Jan 10. doi: 10.1001/jama.2023.26608.
      PubMed: https://www.amedeo.com/p2.php?id=38198193&s=cov&pm=2
       
      Share: https://m.amedeo.com/38198193
    26. KAPOOR N, Dietz C, Buettner BP.
      An Incarcerated Individual With Weight Loss and Interstitial Pulmonary Infiltrates.
      JAMA. 2024 Jan 8. doi: 10.1001/jama.2023.24260.
      PubMed: https://www.amedeo.com/p2.php?id=38190148&s=cov&pm=2
       
      Share: https://m.amedeo.com/38190148
    27. MARKS P, Califf R.
      Is Vaccination Approaching a Dangerous Tipping Point?
      JAMA. 2024 Jan 5. doi: 10.1001/jama.2023.27685.
      PubMed: https://www.amedeo.com/p2.php?id=38180773&s=cov&pm=2
       
      Share: https://m.amedeo.com/38180773
    28. PAYNE AB, Novosad S, Wiegand RE, Najdowski M, et al.
      Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19-Related Thromboembolic Events Among Medicare Enrollees Aged >/=65 Years and Those with End Stage Renal Disease – United States, September 2022-March 2023.
      MMWR Morb Mortal Wkly Rep. 2024;73:16-23.
      PubMed: https://www.amedeo.com/p2.php?id=38206877&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38206877
    29. CHA MJ, Solomon JJ, Lee JE, Choi H, et al.
      Chronic Lung Injury after COVID-19 Pneumonia: Clinical, Radiologic, and Histopathologic Perspectives.
      Radiology. 2024;310:e231643.
      PubMed: https://www.amedeo.com/p2.php?id=38193836&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38193836
    30. COHEN J.
      Covid’s cold cousins.
      Science. 2024;383:141-145.
      PubMed: https://www.amedeo.com/p2.php?id=38207045&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38207045
    31. NACHMAN S, Aldrovandi G.
      Breastfeeding in the United States Among Women With HIV: Con Viewpoint.
      Clin Infect Dis. 2024 Jan 8:ciad778. doi: 10.1093.
      PubMed: https://www.amedeo.com/p2.php?id=38185124&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38185124
    32. COSSMANN A, Hoffmann M, Stankov MV, Lurken K, et al.
      Immune responses following BNT162b2 XBB.1.5 vaccination in patients on haemodialysis in Germany.
      Lancet Infect Dis. 2024 Jan 8:S1473-3099(23)00783.
      PubMed: https://www.amedeo.com/p2.php?id=38211602&s=cov&pm=2
       
      Share: https://m.amedeo.com/38211602
    33. KOSUGI Y, Kaku Y, Hinay AA Jr, Guo Z, et al.
      Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent vaccine in infection-naive and XBB-infected individuals.
      Lancet Infect Dis. 2024 Jan 8:S1473-3099(23)00784.
      PubMed: https://www.amedeo.com/p2.php?id=38211599&s=cov&pm=2
       
      Share: https://m.amedeo.com/38211599
    34. HANSEN CH, Moustsen-Helms IR, Rasmussen M, Soborg B, et al.
      Short-term effectiveness of the XBB.1.5 updated COVID-19 vaccine against hospitalisation in Denmark: a national cohort study.
      Lancet Infect Dis. 2024 Jan 5:S1473-3099(23)00746.
      PubMed: https://www.amedeo.com/p2.php?id=38190834&s=cov&pm=2
       
      Share: https://m.amedeo.com/38190834
    35. KAKU Y, Okumura K, Padilla-Blanco M, Kosugi Y, et al.
      Virological characteristics of the SARS-CoV-2 JN.1 variant.
      Lancet Infect Dis. 2024 Jan 3:S1473-3099(23)00813.
      PubMed: https://www.amedeo.com/p2.php?id=38184005&s=cov&pm=2
       
      Share: https://m.amedeo.com/38184005
    36. GOVEDNIK T, Lainscek D, Kuhar U, Lachish M, et al.
      TXM peptides inhibit SARS-CoV-2 infection, syncytia formation, and lower inflammatory consequences.
      Antiviral Res. 2024 Jan 9:105806. doi: 10.1016/j.antiviral.2024.105806.
      PubMed: https://www.amedeo.com/p2.php?id=38211737&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38211737
    37. GARCIA-RODRIGUEZ I, Moreni G, Capendale PE, Mulder L, et al.
      Assessment of the broad-spectrum host targeting antiviral efficacy of halofuginone hydrobromide in human airway, intestinal and brain organotypic models.
      Antiviral Res. 2024 Jan 6:105798. doi: 10.1016/j.antiviral.2024.105798.
      PubMed: https://www.amedeo.com/p2.php?id=38190972&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38190972

    https://etidioh.wordpress.com/2024/01/14/coronavirus-disease-research-references-by-amedeo-january-14-24/

    #betacoronavirus #coronavirus #covid #COVID19 #health #research #sarbecovirus #sarsCov2

    #betacoronavirus #coronavirus #covid #covid19 #health #research
  29. ETIDIoH @[email protected] ·
    1. NGO B, Rendell MS.
      Major Update: Masks for Prevention of SARS-CoV-2 in Health Care and Community
      Settings.
      Ann Intern Med. 2023;176:eL230358.
      PubMed: https://www.amedeo.com/p2.php?id=38109756&s=cov&pm=2
       
      Share: https://m.amedeo.com/38109756
    2. BROWN TS, Mohareb AM, LaRocque RC.
      Universal Masking in Health Care Settings.
      Ann Intern Med. 2023;176:eL230347.
      PubMed: https://www.amedeo.com/p2.php?id=38109751&s=cov&pm=2
       
      Share: https://m.amedeo.com/38109751
    3. REZNICK SE.
      Universal Masking in Health Care Settings.
      Ann Intern Med. 2023;176:eL230346.
      PubMed: https://www.amedeo.com/p2.php?id=38109749&s=cov&pm=2
       
      Share: https://m.amedeo.com/38109749
    4. JIRMANUS LZ, Schwartzmann EG, Davids JD, Gullette MM, et al.
      Universal Masking in Health Care Settings.
      Ann Intern Med. 2023;176:eL230350.
      PubMed: https://www.amedeo.com/p2.php?id=38109748&s=cov&pm=2
       
      Share: https://m.amedeo.com/38109748
    5. SHENOY ES, Doron S, Branch-Elliman W.
      Universal Masking in Health Care Settings.
      Ann Intern Med. 2023;176:eL230351.
      PubMed: https://www.amedeo.com/p2.php?id=38109747&s=cov&pm=2
       
      Share: https://m.amedeo.com/38109747
    6. GAFFNEY A, Himmelstein DU, Woolhandler S.
      Asthma Disparities in the United States Narrowed During the COVID-19 Pandemic:
      Findings From a National Survey, 2019 to 2022.
      Ann Intern Med. 2023 Dec 19. doi: 10.7326/M23-2100.
      PubMed: https://www.amedeo.com/p2.php?id=38109736&s=cov&pm=2
       
      Share: https://m.amedeo.com/38109736
    7. LOOI MK.
      Covid-19: WHO adds JN.1 as new variant of interest.
      BMJ. 2023;383:p2975.
      PubMed: https://www.amedeo.com/p2.php?id=38128957&s=cov&pm=2
       
      Share: https://m.amedeo.com/38128957
    8. ALTMANN DM, Pagel C.
      Long covid: where are we, what does it say about our pandemic response, and where
      next?
      BMJ. 2023;383:p2972.
      PubMed: https://www.amedeo.com/p2.php?id=38114255&s=cov&pm=2
       
      Share: https://m.amedeo.com/38114255
    9. IACOBUCCI G.
      Flu and covid levels rise in England.
      BMJ. 2023;383:p2965.
      PubMed: https://www.amedeo.com/p2.php?id=38114251&s=cov&pm=2
       
      Share: https://m.amedeo.com/38114251
    10. IACOBUCCI G.
      Covid-19: Bereaved families group collects BMJ award for holding ministers to
      account.
      BMJ. 2023;383:2955.
      PubMed: https://www.amedeo.com/p2.php?id=38101907&s=cov&pm=2
       
      Share: https://m.amedeo.com/38101907
    11. BALABAN N, Mohyuddin GR, Kashi A, Massarweh A, et al.
      Projecting complete redaction of clinical trial protocols (RAPTURE): redacted
      cross sectional study.
      BMJ. 2023;383:e077329.
      PubMed: https://www.amedeo.com/p2.php?id=38097263&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38097263
    12. IACOBUCCI G.
      Covid inquiry: What did Johnson say about underestimated risks, excess deaths,
      and his missing WhatsApps?
      BMJ. 2023;383:2914.
      PubMed: https://www.amedeo.com/p2.php?id=38081644&s=cov&pm=2
       
      Share: https://m.amedeo.com/38081644
    13. LIU W, Gong F, Zheng X, Pei L, et al.
      Factors associated with prolonged viral shedding of SARS-CoV-2 Omicron variant
      infection in Shanghai: A multicenter, retrospective, observational study.
      J Med Virol. 2023;95:e29342.
      PubMed: https://www.amedeo.com/p2.php?id=38130170&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38130170
    14. LEE DH, Han E, Ryu S, Choi HJ, et al.
      Clinical performance of the STANDARD M10 SARS-CoV-2 rapid RT-PCR assay in
      patients visiting an emergency department.
      J Med Virol. 2023;95:e29330.
      PubMed: https://www.amedeo.com/p2.php?id=38117224&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38117224
    15. KAPUSTA J, Babicki M, Pieniawska-Smiech K, Kaluzinska-Kolat Z, et al.
      Clinical and electrocardiographic correlates of myocardial dysfunction after
      COVID-19 in nonhospitalised patients in long-term follow-up. Data from the polish
      long-covid cardiovascular study.
      J Med Virol. 2023;95:e29331.
      PubMed: https://www.amedeo.com/p2.php?id=38112151&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38112151
    16. ZHOU Y, Liu Y, Jiang L, Zhang R, et al.
      Azvudine and nirmatrelvir-ritonavir in hospitalized patients with
      moderate-to-severe COVID-19: Emulation of a randomized target trial.
      J Med Virol. 2023;95:e29318.
      PubMed: https://www.amedeo.com/p2.php?id=38112106&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38112106
    17. SULLIVAN DJ, Focosi D, Hanley DF, Cruciani M, et al.
      Outpatient randomized controlled trials to reduce COVID-19 hospitalization:
      Systematic review and meta-analysis.
      J Med Virol. 2023;95:e29310.
      PubMed: https://www.amedeo.com/p2.php?id=38105461&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38105461
    18. LI Y, Yamamoto S, Horii K, Mizoue T, et al.
      Long COVID during the Omicron predominant waves among Japanese healthcare
      workers.
      J Med Virol. 2023;95:e29322.
      PubMed: https://www.amedeo.com/p2.php?id=38103017&s=cov&pm=2
       
      Share: https://m.amedeo.com/38103017
    19. FEGHOUL L, Caillault A, Peyrony O, Salmona M, et al.
      Respiratory torque teno virus load at emergency department visit predicts
      intensive care unit admission of SARS-CoV-2 infected patients.
      J Med Virol. 2023;95:e29319.
      PubMed: https://www.amedeo.com/p2.php?id=38102899&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38102899
    20. ALLEL K, Cabada MM, Lau C, Mills D, et al.
      Causes of death among international travellers in Peru, 2017 to 2021.
      J Travel Med. 2023 Dec 21:taad163. doi: 10.1093.
      PubMed: https://www.amedeo.com/p2.php?id=38127642&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38127642
    21. GAO Q, Weng Z, Feng Y, Gong T, et al.
      KPNA2 suppresses porcine epidemic diarrhea virus replication by targeting and
      degrading virus envelope protein through selective autophagy.
      J Virol. 2023;97:e0011523.
      PubMed: https://www.amedeo.com/p2.php?id=38038431&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38038431
    22. HARRIS E.
      Using Throat Swabs Improved Sensitivity in Detecting SARS-CoV-2.
      JAMA. 2023 Dec 20. doi: 10.1001/jama.2023.25267.
      PubMed: https://www.amedeo.com/p2.php?id=38117510&s=cov&pm=2
       
      Share: https://m.amedeo.com/38117510
    23. HARRIS E.
      Program Offering Free COVID-19 and Flu Services Expands Nationwide.
      JAMA. 2023 Dec 20. doi: 10.1001/jama.2023.25268.
      PubMed: https://www.amedeo.com/p2.php?id=38117506&s=cov&pm=2
       
      Share: https://m.amedeo.com/38117506
    24. CHARLIER P.
      Death and end of life in France after COVID-19.
      Lancet. 2023;402:2290.
      PubMed: https://www.amedeo.com/p2.php?id=38103938&s=cov&pm=2
       
      Share: https://m.amedeo.com/38103938
    25. HORTON R.
      Offline: Boris Johnson and COVID-19-more light than heat.
      Lancet. 2023;402:2277.
      PubMed: https://www.amedeo.com/p2.php?id=38103935&s=cov&pm=2
       
      Share: https://m.amedeo.com/38103935
    26. BLACK CL, Kriss JL, Razzaghi H, Patel SA, et al.
      Influenza, Updated COVID-19, and Respiratory Syncytial Virus Vaccination Coverage
      Among Adults – United States, Fall 2023.
      MMWR Morb Mortal Wkly Rep. 2023;72:1377-1382.
      PubMed: https://www.amedeo.com/p2.php?id=38127675&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38127675
    27. HARRINGTON PR, Cong J, Troy SB, Rawson JMO, et al.
      Evaluation of SARS-CoV-2 RNA Rebound After Nirmatrelvir/Ritonavir Treatment in
      Randomized, Double-Blind, Placebo-Controlled Trials – United States and
      International Sites, 2021-2022.
      MMWR Morb Mortal Wkly Rep. 2023;72:1365-1370.
      PubMed: https://www.amedeo.com/p2.php?id=38127674&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38127674
    28. RESES HE, Dubendris H, Haas L, Barbre K, et al.
      Coverage with Influenza, Respiratory Syncytial Virus, and Updated COVID-19
      Vaccines Among Nursing Home Residents – National Healthcare Safety Network,
      United States, December 2023.
      MMWR Morb Mortal Wkly Rep. 2023;72:1371-1376.
      PubMed: https://www.amedeo.com/p2.php?id=38127673&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38127673
    29. SMITH DJ, Lambrou A, Patel P.
      SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral Antivirals.
      MMWR Morb Mortal Wkly Rep. 2023;72:1357-1364.
      PubMed: https://www.amedeo.com/p2.php?id=38127665&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38127665
    30. Covid Update: ITT Episode 23.
      N Engl J Med. 2023;389:e52.
      PubMed: https://www.amedeo.com/p2.php?id=38118021&s=cov&pm=2
       
      Share: https://m.amedeo.com/38118021
    31. BENZLER J.
      Contact-tracing app predicts risk of SARS-CoV-2 transmission.
      Nature. 2023 Dec 21. doi: 10.1038/d41586-023-04063.
      PubMed: https://www.amedeo.com/p2.php?id=38129614&s=cov&pm=2
       
      Share: https://m.amedeo.com/38129614
    32. FERRETTI L, Wymant C, Petrie J, Tsallis D, et al.
      Digital measurement of SARS-CoV-2 transmission risk from 7 million contacts.
      Nature. 2023 Dec 20. doi: 10.1038/s41586-023-06952.
      PubMed: https://www.amedeo.com/p2.php?id=38122820&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38122820
    33. HALL S.
      Vaccines reduce the risk of long COVID in children.
      Nature. 2023 Dec 20. doi: 10.1038/d41586-023-04032.
      PubMed: https://www.amedeo.com/p2.php?id=38114835&s=cov&pm=2
       
      Share: https://m.amedeo.com/38114835
    34. SUTHAR PP, Hughes K, Mafraji M, Akyuz M, et al.
      Case 324.
      Radiology. 2023;309:e222747.
      PubMed: https://www.amedeo.com/p2.php?id=38112552&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38112552
    35. ABEGAZ FA, Dos Santos PT, Mogeni OD, Guarnacci T, et al.
      Evaluating Quality Management and Diagnostics Microbiology Performance Within an
      International External Quality Assessment (EQA) Program Serving National One
      Health Sector Reference Laboratories Across Asia: Experience Amid the Coronavirus
      Disease 2019 (COVID-19) Pandemic.
      Clin Infect Dis. 2023;77.
      PubMed: https://www.amedeo.com/p2.php?id=38118017&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38118017
    36. KWON SY, Gautam S, Poudel K, Banneheke H, et al.
      Utility and Evaluation of Applied Project Management Processes Within a Large
      Multicountry Health Systems Development Project Conducted During the Coronavirus
      Disease 2019 (COVID-19) Pandemic.
      Clin Infect Dis. 2023;77.
      PubMed: https://www.amedeo.com/p2.php?id=38118010&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38118010
    37. MUSTAFA T, Niazi MRK, Lakdawala Z, Mirza S, et al.
      Regional and National Trends in Consumption of Antimicrobials in Pakistan; Pre
      and Post-COVID (2019-2021).
      Clin Infect Dis. 2023;77.
      PubMed: https://www.amedeo.com/p2.php?id=38118009&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38118009
    38. LESLIE T, Parry C, Ondoa P, Walsh T, et al.
      The Reality of Antimicrobial Resistance and Antibiotic Usage Data in Asia: The
      CAPTURA Experience.
      Clin Infect Dis. 2023;77.
      PubMed: https://www.amedeo.com/p2.php?id=38118008&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38118008
    39. HAYDEN MK, Hanson KE, Englund JA, Lee MJ, et al.
      The Infectious Diseases Society of America Guidelines on the Diagnosis of
      Coronavirus Disease 2019 (COVID-19): Molecular Diagnostic Testing.
      Clin Infect Dis. 2023 Dec 19:ciad646. doi: 10.1093.
      PubMed: https://www.amedeo.com/p2.php?id=38112284&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38112284
    40. SMITH TC.
      Long COVID: Alice Evans, Brucellosis, and Reflections on Infectious Causes of
      Chronic Disease.
      Clin Infect Dis. 2023;77:1644-1647.
      PubMed: https://www.amedeo.com/p2.php?id=37462272&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/37462272
    41. MONTGOMERY MP, Morris SE, Rolfes MA, Kittikraisak W, et al.
      The role of asymptomatic infections in influenza transmission: what do we really
      know.
      Lancet Infect Dis. 2023 Dec 18:S1473-3099(23)00619.
      PubMed: https://www.amedeo.com/p2.php?id=38128563&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38128563
    42. YANG S, Yu Y, Xu Y, Jian F, et al.
      Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure.
      Lancet Infect Dis. 2023 Dec 15:S1473-3099(23)00744.
      PubMed: https://www.amedeo.com/p2.php?id=38109919&s=cov&pm=2
       
      Share: https://m.amedeo.com/38109919
    43. GANDHI M.
      Post-viral sequelae of COVID-19 and influenza.
      Lancet Infect Dis. 2023 Dec 14:S1473-3099(23)00762.
      PubMed: https://www.amedeo.com/p2.php?id=38104584&s=cov&pm=2
       
      Share: https://m.amedeo.com/38104584
    44. XIE Y, Choi T, Al-Aly Z.
      Long-term outcomes following hospital admission for COVID-19 versus seasonal
      influenza: a cohort study.
      Lancet Infect Dis. 2023 Dec 14:S1473-3099(23)00684.
      PubMed: https://www.amedeo.com/p2.php?id=38104583&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38104583
    45. WANG S, Wang Z, Li Y, Tu S, et al.
      Generation of whole-porcine neutralizing antibodies of an alphacoronavirus by
      single B cell antibody technology.
      Antiviral Res. 2023;220:105754.
      PubMed: https://www.amedeo.com/p2.php?id=37967753&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/37967753

    https://etidioh.wordpress.com/2023/12/25/coronavirus-disease-research-references-by-amedeo-december-25-23/

    #betacoronavirus #coronavirus #COVID19 #research #sarbecovirus #sarsCov2

    #betacoronavirus #coronavirus #covid19 #research #sarbecovirus #sarscov2
  30. ETIDIoH @[email protected] ·
    1. PLATT A, Singh M, Stein S, Soherwardi S, et al.
      Replication-Competent Virus Detected in Blood of a Fatal COVID-19 Case.
      Ann Intern Med. 2023 Dec 12. doi: 10.7326/L23-0253.
      PubMed: https://www.amedeo.com/p2.php?id=38079637&s=cov&pm=2
       
      Share: https://m.amedeo.com/38079637
    2. ARSHAD Z, Nazareth J, Pareek M.
      Learning to live with covid-19: testing, vaccination, and mask wearing still play
      a key part in managing the pandemic.
      BMJ. 2023;383:p2943.
      PubMed: https://www.amedeo.com/p2.php?id=38097251&s=cov&pm=2
       
      Share: https://m.amedeo.com/38097251
    3. WISE J.
      Covid-19: Preliminary figures show 1.2% of people in England had infection at end
      of November.
      BMJ. 2023;383:p2917.
      PubMed: https://www.amedeo.com/p2.php?id=38081655&s=cov&pm=2
       
      Share: https://m.amedeo.com/38081655
    4. PETERS MA, Cloete K, Odwe G, Tadele G, et al.
      Embedding implementation research to cross the quality of care chasm during the
      covid-19 pandemic and beyond.
      BMJ. 2023;383:e076331.
      PubMed: https://www.amedeo.com/p2.php?id=38081643&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38081643
    5. ZVIEDRITE N, Jahan F, Moreland S, Ahmed F, et al.
      COVID-19-Related School Closures, United States, July 27, 2020-June 30, 2022.
      Emerg Infect Dis. 2023;30.
      PubMed: https://www.amedeo.com/p2.php?id=38086396&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38086396
    6. TSOI JYH, Cai J, Situ J, Lam WJ, et al.
      Autoantibodies against angiotensin-converting enzyme 2 (ACE2) after COVID-19
      infection or vaccination.
      J Med Virol. 2023;95:e29313.
      PubMed: https://www.amedeo.com/p2.php?id=38100626&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38100626
    7. MEISTER TL, Kirchhoff L, Bruggemann Y, Todt D, et al.
      Stability of pathogens on banknotes and coins: A narrative review.
      J Med Virol. 2023;95:e29312.
      PubMed: https://www.amedeo.com/p2.php?id=38100621&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38100621
    8. CHEN Q, Qin S, Zhou HY, Deng YQ, et al.
      Competitive fitness and homologous recombination of SARS-CoV-2 variants of
      concern.
      J Med Virol. 2023;95:e29278.
      PubMed: https://www.amedeo.com/p2.php?id=38088537&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38088537
    9. YIN ZJ, Xiao H, McDonald S, Brusic V, et al.
      Dynamically adjustable SVEIR(MH) model of multiwave epidemics: Estimating the
      effects of public health measures against COVID-19.
      J Med Virol. 2023;95:e29301.
      PubMed: https://www.amedeo.com/p2.php?id=38087460&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38087460
    10. LI J, Mao H, Song W, Chen Y, et al.
      Low neutralization of SARS-CoV-2 Omicron BA.5.2.48, BF.7.14, XBB.1 subvariants by
      homologous or heterologous booster.
      J Med Virol. 2023;95:e29306.
      PubMed: https://www.amedeo.com/p2.php?id=38084772&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38084772
    11. BENNING L, Bartenschlager M, Kim H, Kalble F, et al.
      Live-virus serum neutralization after bivalent SARS-CoV-2 mRNA vaccination in
      hemodialysis patients.
      J Med Virol. 2023;95:e29303.
      PubMed: https://www.amedeo.com/p2.php?id=38082556&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38082556
    12. FUKUDA Y, Togashi A, Hirakawa S, Yamamoto M, et al.
      Resurgence of human metapneumovirus infection and influenza after three seasons
      of inactivity in the post-COVID-19 era in Hokkaido, Japan, 2022-2023.
      J Med Virol. 2023;95:e29299.
      PubMed: https://www.amedeo.com/p2.php?id=38081792&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38081792
    13. WANG R, Guo J, Lu J, Du P, et al.
      A potential broad-spectrum neutralizing antibody against Betacoronavirus.
      J Med Virol. 2023;95:e29252.
      PubMed: https://www.amedeo.com/p2.php?id=38078658&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38078658
    14. XIAO Y, Chang L, Ji H, Sun H, et al.
      Posttranslational modifications of ACE2 protein: Implications for SARS-CoV-2
      infection and beyond.
      J Med Virol. 2023;95:e29304.
      PubMed: https://www.amedeo.com/p2.php?id=38063421&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38063421
    15. ANAGNOSTOPOULOS A, Fehr J.
      Rebound and steep increase of international travel after the COVID-19 pandemic:
      where are we going from here?
      J Travel Med. 2023 Dec 14:taad158. doi: 10.1093.
      PubMed: https://www.amedeo.com/p2.php?id=38097384&s=cov&pm=2
       
      Share: https://m.amedeo.com/38097384
    16. FU Z, Xiang Y, Fu Y, Su Z, et al.
      DYRK1A is a multifunctional host factor that regulates coronavirus replication in
      a kinase-independent manner.
      J Virol. 2023 Dec 15:e0123923. doi: 10.1128/jvi.01239.
      PubMed: https://www.amedeo.com/p2.php?id=38099687&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38099687
    17. DOMINGO E, Martinez-Gonzalez B, Garcia-Crespo C, Somovilla P, et al.
      Puzzles, challenges, and information reservoir of SARS-CoV-2 quasispecies.
      J Virol. 2023 Nov 21:e0151123. doi: 10.1128/jvi.01511.
      PubMed: https://www.amedeo.com/p2.php?id=38092661&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38092661
    18. BOLLAND W, Michel V, Planas D, Hubert M, et al.
      High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1.
      J Virol. 2023 Dec 13:e0135123. doi: 10.1128/jvi.01351.
      PubMed: https://www.amedeo.com/p2.php?id=38088562&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38088562
    19. JERONIMO PMC, Aksenen CF, Duarte IO, Lins RD, et al.
      Evolutionary deletions within the SARS-CoV-2 genome as signature trends for virus
      fitness and adaptation.
      J Virol. 2023 Dec 13:e0140423. doi: 10.1128/jvi.01404.
      PubMed: https://www.amedeo.com/p2.php?id=38088350&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38088350
    20. GAO W, Wang L, Cui W, Wang H, et al.
      Deubiquitinase USP1 regulates sarbecovirus ORF6 protein function.
      J Virol. 2023 Dec 12:e0143723. doi: 10.1128/jvi.01437.
      PubMed: https://www.amedeo.com/p2.php?id=38084957&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38084957
    21. HARRIS E.
      Life Expectancy in US Climbed After Declines Related to COVID-19.
      JAMA. 2023 Dec 13. doi: 10.1001/jama.2023.24683.
      PubMed: https://www.amedeo.com/p2.php?id=38090999&s=cov&pm=2
       
      Share: https://m.amedeo.com/38090999
    22. SURAN M.
      Studies Investigate Whether Antivirals Like Paxlovid May Prevent Long COVID.
      JAMA. 2023 Dec 13. doi: 10.1001/jama.2023.24103.
      PubMed: https://www.amedeo.com/p2.php?id=38090997&s=cov&pm=2
       
      Share: https://m.amedeo.com/38090997
    23. SPENCER H, Jorgensen E, Seo J, Robinson C, et al.
      Notes from the Field: COVID-19 Pandemic-Related Changes in Blood Lead Screening –
      Chicago, Illinois, 2017-2022.
      MMWR Morb Mortal Wkly Rep. 2023;72:1353-1354.
      PubMed: https://www.amedeo.com/p2.php?id=38096125&s=cov&pm=2
       
      Share: https://m.amedeo.com/38096125
    24. MCMAHAN K, Wegmann F, Aid M, Sciacca M, et al.
      Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques.
      Nature. 2023 Dec 14. doi: 10.1038/s41586-023-06951.
      PubMed: https://www.amedeo.com/p2.php?id=38096903&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38096903
    25. XING Z, Jeyanathan M.
      A next-generation inhalable dry powder COVID vaccine.
      Nature. 2023 Dec 13. doi: 10.1038/d41586-023-03557.
      PubMed: https://www.amedeo.com/p2.php?id=38093042&s=cov&pm=2
       
      Share: https://m.amedeo.com/38093042
    26. What makes people with diabetes more susceptible to serious lung infections?
      Nature. 2023 Dec 13. doi: 10.1038/d41586-023-03647.
      PubMed: https://www.amedeo.com/p2.php?id=38093039&s=cov&pm=2
       
      Share: https://m.amedeo.com/38093039
    27. NOBS SP, Kolodziejczyk AA, Adler L, Horesh N, et al.
      Lung dendritic-cell metabolism underlies susceptibility to viral infection in
      diabetes.
      Nature. 2023 Dec 13. doi: 10.1038/s41586-023-06803.
      PubMed: https://www.amedeo.com/p2.php?id=38093014&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38093014
    28. YE T, Jiao Z, Li X, He Z, et al.
      Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization.
      Nature. 2023 Dec 13. doi: 10.1038/s41586-023-06809.
      PubMed: https://www.amedeo.com/p2.php?id=38093012&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38093012
    29. RUGGERI K, Stock F, Haslam SA, Capraro V, et al.
      A synthesis of evidence for policy from behavioural science during COVID-19.
      Nature. 2023 Dec 13. doi: 10.1038/s41586-023-06840.
      PubMed: https://www.amedeo.com/p2.php?id=38093007&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38093007
    30. SCIENCE M, Orkin J, Maguire B, Bitnun A, et al.
      Viral dynamics of the SARS-CoV-2 Omicron Variant in Paediatric Patients; A
      prospective cohort study.
      Clin Infect Dis. 2023 Dec 12:ciad740. doi: 10.1093.
      PubMed: https://www.amedeo.com/p2.php?id=38084906&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38084906
    31. RAMAN B, Ramasamy MN.
      Synbiotics in post-acute COVID-19 syndrome-a potential new treatment framework?
      Lancet Infect Dis. 2023 Dec 7:S1473-3099(23)00735.
      PubMed: https://www.amedeo.com/p2.php?id=38071991&s=cov&pm=2
       
      Share: https://m.amedeo.com/38071991
    32. LAU RI, Su Q, Lau ISF, Ching JYL, et al.
      A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong
      (RECOVERY): a randomised, double-blind, placebo-controlled trial.
      Lancet Infect Dis. 2023 Dec 7:S1473-3099(23)00685.
      PubMed: https://www.amedeo.com/p2.php?id=38071990&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38071990
    33. ZUO F, Cao Y, Sun R, Yisimayi A, et al.
      Neutralisation activity of mucosal IgA against XBB sublineages and BA.2.86.
      Lancet Infect Dis. 2023 Dec 7:S1473-3099(23)00732.
      PubMed: https://www.amedeo.com/p2.php?id=38071989&s=cov&pm=2
       
      Share: https://m.amedeo.com/38071989
    34. CARR EJ, Dowgier G, Greenwood D, Herman LS, et al.
      SARS-CoV-2 mucosal neutralising immunity after vaccination.
      Lancet Infect Dis. 2023 Dec 6:S1473-3099(23)00705.
      PubMed: https://www.amedeo.com/p2.php?id=38070528&s=cov&pm=2
       
      Share: https://m.amedeo.com/38070528
    35. AKSU M, Kumar P, Guttler T, Taxer W, et al.
      Nanobodies to multiple spike variants and inhalation of nanobody-containing
      aerosols neutralize SARS-CoV-2 in cell culture and hamsters.
      Antiviral Res. 2023 Dec 6:105778. doi: 10.1016/j.antiviral.2023.105778.
      PubMed: https://www.amedeo.com/p2.php?id=38065245&s=cov&pm=2
      ABSTRACT available
      Share: https://m.amedeo.com/38065245

    https://etidioh.wordpress.com/2023/12/16/coronavirus-disease-research-references-by-amedeo-december-16-23/

    #betacoronavirus #coronavirus #covid #COVID19 #health #pandemic #research #sarbecovirus #sarsCov2

    #betacoronavirus #coronavirus #covid #covid19 #health #pandemic
Next page